1. Basic and Clinical Neuroscience, Clinical Neurosciences Clinical Academic Group, King's College London, London, United Kingdom;
2. Department of Brain Science, Imperial College London, London, United Kingdom;
3. Elettra Sincrotrone Trieste, Basovizza, Trieste, ItalyStructural Biology; NMR; Protein Aggregation; Neurodegeneration; Muscle Proteins; Macromolecular Interactions
Professor of Chemistry and Molecular Biology at King's College London
Distinguished Scientist at Elettra Sincrotrone Trieste affiliated also Imperial College London
Full Professor at the Scuola Normale Superiore di Pisa
Member of the Academia Europaea (MAE), AcademiaNet and the European Molecular Biology Organization
SAB Member for the ALBA Spanish Synchrotron (2022-present)
Elected Committee Member of Novo Nordisk Foundation (2023-2027)
Elected Member of the Ampere NMR Committee (2022-2027)
Member of the Scientific Advisory Board of CERIC (C-European Research Infrastructure Consortium) (2011 - present)
Panel Member of the Scientific Advisory Board of University Autonoma Catalunya (2016-present)
1. Centre for Precision Health, Edith Cowan University, Perth, Australia;
2. Institute for Glycome Study, Shantou University Medical College, Shantou, China;
3. School of Medical and Health Sciences, Edith Cowan University, Perth, AustraliaGlycomics; Public Health; Genetic Epidemiology; Chronic Disorders
Professor of Public Health in the Centre for Precision Health and School of Medical and Health Sciences
Member of the Standing Committee of the Human Glycome Project
Australian National Representative of European Association of Preventive, Predictive and Personalised Medicine (EPMA)
Fellow of Public Health, Royal College of Physicians, United Kingdom (FFPH)
Fellow of the Royal Society of Biology of United Kingdom (FRSB)
Fellow of the Royal Society of Medicine of United Kingdom (FRSM)
Academic editor of PloS ONE (PLOS)
Associate editor of EPMA Journal (Springer-Nature)
Regional editor of Journal of Global Health (Edinburgh University Press)
Regional editor of OMICS: A Journal of Integrative Biology (Mary Ann Liebert)
Regional editor of Journal of Human Hypertension (Nature)
Leader of the Suboptimal Health and Glycomics research group, within the School of Medical and Health Sciences, and is the Suboptimal Health Program Lead in the Centre for Precision Health, an ECU strategic Research Centre
1. Department of Physics and Astronomy "G.Galilei", University of Padua, Padova, Italy
2. Veneto Institute of Molecular Medicine (VIMM), Padova, Italy
3. Padova Neuroscience Center, Padova, ItalyCharcot-marie-tooth; Parkinson’s Diseases; Bioinformatics; Biology
Associate Professor at the Dept. of Physics and Astronomy, University of Padova
Scientific Cordinator and Executive (VP, SVP, CFO, CTO etc.) of PNC-SISMUR Infrastructure for Cellular Imaging at the Venetian Institute of Molecular Medicine (VIMM), Padova
Group Leader at the Venetian Institute of Molecular Medicine (VIMM), Padova
1. Western University of Health Sciences, Graduate School of Biomedical Science, Pomona, CA, United States;
2. Department of Psychiatry Wright University Boonshoft School of Medicine, Dayton, OH, United States;
3. Human Integrated Services Unit University of Vermont Center for Clinical & Translational Science, College of Medicine, Burlington, VT, United StatesGenetics of Alcoholism; Neuropsychiatry and Genetics; Nutritional Genetics; Pharmacogenetics
Well-known American Scientist in Psychopharmacology and Psychiatric Genetics.
Distinguished Top Professional to be featured in the Wall Street Journal.
Editor -in-Chief of Current Psychopharmacology, Addiction Psychiatry, and Theranostic and Pharmacological Sciences.
Associate Editor for Frontiers in Psychiatry and Frontiers in Public Health
Regional Editor for Current Pharmaceutical & Biotechnology. Recipient of NIH grants and has been awarded Lifetime Achievements,
Distinguished Honorary Doctors of Humane Letters;
Life-time Honorary Professor at ELTE Eötvös Loránd University, Hungary
Distinguished Honorary Professor at Adelson School of Medicine, Ariel University, Israel.
Adjunct professor at Western University, University of Vermont, Wright School of Medicine
Executive Chairman and CEO of TranspliceGen Therapeutics, Inc.
Stanford university credited him as top 2% of the World Best scientist list (2023).
The International Research Awards on Neurology and Neuro Disorders awarded him the “Best Researcher Award 2023”.
Instituto de Biomedicina de Sevilla, Consejo Superior de Investigaciones Científicas, Avda. Manuel Siurot s/n, Seville, SpainIdentification of new genes involved in cancer; Its characterization and translation to clinic; Identification and validation of new targets for anticancer drug discovery
Head of the Assay Development Group at the Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid
Leader of the Molecular Biology of Cancer Lab in Biomedical Institute of Seville (IBiS/CSIC)
1. Henan Key Laboratory of Microbiome and Esophageal Cancer Prevention and Treatment;
2. Henan Key Laboratory of Cancer Epigenetics;
3. Cancer Hospital, The First Affiliated Hospital（College of Clinical Medicine）of Henan University of Science and Technology, ChinaBasic and Clinical Research on Gastrointestinal Cancer
Deputy Dean, Medical College, Henan University of Science and Technology
President, The First Affiliated Hospital of Henan University of Science and Technology
President, Cancer Hospital, The First Affiliated Hospital of Henan University of Science and Technology
Editor-in-Chief, Esophageal Cancer and Diseases of the Esophagus
Director, Esophageal Photodynamic Therapy Training Base, China
Director, Henan Provincial Key Laboratory of Epigenetics
Director, Henan Provincial International Joint Key Laboratory of Infection and Esophageal Cancer
Director, Henan Provincial Engineering Research Center for Esophageal Cancer Prevention and Control
Director, Henan Provincial Academician Workstation for Esophageal Cancer Prevention and Control
Discipline Leader, Medical Bioinformatics Ph.D. Program, Henan University of Science and Technology
Professional Memberships and Leadership Roles:
Member, American Society of Clinical Oncology (ASCO)
Chair, Esophageal Cancer Committee, Chinese Society of Clinical Oncology (CSCO)
Vice Chair, Photodynamic Therapy Committee, Chinese Anti-Cancer Association (CACA)
Vice Chair, Expert Committee on Photodynamic Therapy, Chinese Society of Clinical Oncology (CSCO)
Chair, Henan Provincial Anti-Cancer Association – Esophageal Cancer Committee
Vice Chair, Henan Medical Association – Oncology Committee
Vice President, First Henan Provincial Physicians Association – Oncology Physicians Branch
Vice Chair, Henan Hospital Association – Cancer Hospital/Department Management Branch
Chair, Youth Committee of Henan Provincial Anti-Cancer Association – Precision Medicine
Vice Chair, Henan Provincial Anti-Cancer Association – Chemotherapy Committee
Vice Chair, Henan Provincial Anti-Cancer Association – Photodynamic Therapy Committee
Vice Chair, Henan Provincial Anti-Cancer Association – Tumor Epidemiology and Etiology Committee
Vice Chair, Henan Provincial Anti-Cancer Association – Oncologic Endoscopy Committee
Vice Chair, Henan Provincial Anti-Cancer Association – Committee on Precision Diagnosis and Treatment
Vice Chair, Henan Provincial Anti-Cancer Association – Targeted Therapy Committee
Vice Chair, Henan Provincial Geriatrics Society – Oncology Committee
Vice President, Luoyang Anti-Cancer Association
Chair, Luoyang Municipal Oncology Committee
School of Basic Medical Science, Henan University, Kaifeng, ChinaMedical Microbiology and Immunology; Nuclear Protein PCNP(PEST proteolytic signal-containing nuclear protein); Tumorigenesis; Tumor Suppression Gene
Professor | Vice Dean, School of Medicine, Henan University
Distinguished Professor, The First Affiliated Hospital of Henan University
Vice President, Henan Immunological Society
Director, Henan International Joint Laboratory of Nucleoprotein Gene Regulation
Founder and First Chairman, Henan Industrial Technology Innovation Strategic Alliance for Precision Diagnosis and Treatment of Cancer
Honorary President, Henan Health Science Society
Chief Science Communicator, Henan Science Communication Expert Group
Founder of the Kaifeng Medical Science Communication Team
Council Member, Chinese Society of Microbiology
Former Vice President, Henan Society of Microbiology
Founder and First Chair, Henan Specialized Committee on Infection, Molecular Immunology
Chair, Sub-committee on Biomedical Research Ethics, Henan University
Founder and First Director, Henan Specialized Committee on Infectious Diseases and Biosafety
Founder and Honorary Director, Kaifeng Key Laboratory of Infectious Diseases and Biosafety
School of Basic Medical Sciences, Henan University, Kaifeng, Henan, China.Cell Signaling Transduction; PTEN; CART; Biotechnology
Distinguished Professor, Henan University, Huanghe Scholar
Standing Council Member, Henan Physiological Society
Vice Chair, Professional Committee on Neurobiology
Standing Council Member, Henan Society of Biochemistry and Molecular Biology
Member, Chinese Society of Biochemistry and Molecular Biology
Guangdong Provincial Key Laboratory of Protein Modification and Degradation, State Key Laboratory of Respiratory Diseases, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, Guangdong, ChinaProtein Medications; Carcinogenesis; Treatment
Professor, Guangzhou Medical University, GuangZhou, China
Deputy Director, Guangdong Provincial Key Laboratory of Protein Modification and Degradation
Council Member, Chinese Pharmacological Society
Standing Council Member, Guangdong Pharmacological Society
Secretary, Specialized Committee on Protein Modification and Disease, Chinese Society of Pathophysiology
Vice Chair, Specialized Committee on Drug Screening and Evaluation, Guangdong Pharmacological Society
1. Biobank of Research, IRCCS Azienda Ospedaliera-Universitaria di Bologna Policlinico di S. Orsola, Bologna, Italy;
2. Department of Medical and Surgical Sciences, Alma Mater Studiorum Università di Bologna, Bologna, ItalyLeukemia; Lymphoma; Targeted therapy; Molecular diagnostics; High throughput genomics; Transcriptomics; Digital pathology
Associate Professor of Pathology & Executive Physician, Bologna University, S. Orsola Malpighi Hospital, Bologna, Italy
Adjunct Professor of Hematology and Pathology at Jomo Kenyatta University of Agricolture and Technology, Nairobi, Kenya
Member of the Scientific Committee, Euro-Mediterranean Institute of Science and Technology (IEMEST), Palermo, Italy
National Academic Qualification as Full Professor of Pathology
Associate Editor for the American Journal of Blood Research, Modern Chemotherapy, World Journal of Hematology, Frontiers in Molecular Biosciences, Helyon.
Member of the SIE, SIES, ASH, AACR, SIAPEC/IAP, EHA, ELN/EWALL, FIL
1. Biobank of Research, IRCCS Azienda Ospedaliera-Universitaria di Bologna Policlinico di S. Orsola, Bologna, Italy;
2. Department of Medical and Surgical Sciences, Alma Mater Studiorum Università di Bologna, Bologna, ItalyLeukemia; Lymphoma; Targeted therapy; Molecular diagnostics; High throughput genomics; Transcriptomics; Digital pathology
Associate Professor of Pathology & Executive Physician, Bologna University, S. Orsola Malpighi Hospital, Bologna, Italy
Adjunct Professor of Hematology and Pathology at Jomo Kenyatta University of Agricolture and Technology, Nairobi, Kenya
Member of the Scientific Committee, Euro-Mediterranean Institute of Science and Technology (IEMEST), Palermo, Italy
National Academic Qualification as Full Professor of Pathology
Associate Editor for the American Journal of Blood Research, Modern Chemotherapy, World Journal of Hematology, Frontiers in Molecular Biosciences, Helyon.
Member of the SIE, SIES, ASH, AACR, SIAPEC/IAP, EHA, ELN/EWALL, FIL
Children's Hospital of Eastern Ontario, University of Ottawa, ON, CanadaBiology; pathology of the cardiovascular/gastrointestinal system; gut/bile microbiome; bone cell biology
Chief of the Anatomic Pathology Division at the Children’s Hospital of Eastern Ontario
Professor of Pediatrics and Pathology, University of Alberta and Ottawa, Canada
Consultant of Carcinogenesis in Experimental Animals at the WHO/IARC, Lyon, France
“ad-hoc” Peer-Referee for the National Toxicology Program, NIH, USA
Editor-in-Chief and in the Editorial Board of Prestigious Medical Journals and international agencies
Department of Medical and Surgical Sciences, University Magna Graecia of Catanzaro, Catanzaro, ItalyWound Healing; Vascular Surgery; Metabolic Syndrome; Treatment; Vascular Medicine; Reconstructive Surgery; General Surgery; Surgery; Diabetes; Atherosclerosis
Associate Professor of Vascular Surgery at the University Magna Graecia of Catanzaro, Catanzaro, Italy
Full Professor of Surgery and Vascular Surgery
Academic Head of Calabria Region of Italian Society of Vascular and Endovascular Surgery (SICVE).
"International -1- Member" of the Association for Academic Surgery (AAS).
Holder of “Zaleuco” Prize for Vascular Surgery conferred by Associazione Cenacolo della Cultura e delle Scienze
Department of Pharmaceutical Sciences, College of Pharmacy, University of North Texas Health Science Center, Fort Worth, United StatesDiabetes; Redox Biochemistry; Mitochondrial Oxidative Stress; Acute Kidney Injury; Chronic Kidney Disease
Professor of Pharmaceutical Sciences
Top 2% Worldwide Scientists in the 2024 Edition of Stanford University/Elsevier ranking
Director for a Journal Club Course
Member of American Society for Biochemistry and Molecular Biology
Member of Society for Redox Biology and Medicine
Member of the International Society of Nephrology
Member of the International Society of Neurochemistry
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaBasic and clinical applications of tumor immunotherapy and cell therapy
Director and Professor, Zhengzhou University, China
Recipient of the State Council Special Allowance, China
Academic Vice President, Medical School, Zhengzhou University
Chief Scientist, The First Affiliated Hospital of Zhengzhou University
Director, Biotherapy Center and Division of Bioimmunotherapy, The First Affiliated Hospital of Zhengzhou University
Member, European Society of Immunology (ESI); American Association for Cancer Research (AACR); American Association of Immunologists (AAI)
Council Member, Chinese Society of Immunology
Chair, Professional Committee on Biotherapy, Henan Anti-Cancer Association & Henan Society of Immunology
Executive Vice Chair, Cell Therapy Quality Management and Research Branch, China Quality Management Association for Pharmaceuticals
Vice Chair, Biotherapy Branch, Chinese Society of Research Hospitals
Standing Council Member, Committee on Tumor Immunotherapy, Chinese Anti-Cancer Association (CACA)
Committee Member, Immuno-Oncology Committee, Chinese Society of Clinical Oncology (CSCO)
Department of Microbiology Immunology and Infectious Diseases, University of Calgary, Calgary, Alberta, CanadaAntiviral innate immunity; Herpesviruses; Viral immune evasion mechanism; Emerging viruses; Signaling pathways; Virus-Host interaction
Elsevier's Top 0.5% (2023) and Top 1% (2021-2022) Scientists
Adjunct Professor at the University of Calgary, Calgary, Canada.
Editor of mBio, an Associate Editor of Virology Journal, etc.
Awards: Hundred-Talent Program of the Chinese Academy of Sciences
Top 25 reviewers for the Journal of Virology (2019, 2020, 2021, 2022)
the Publons Top 1% Peer Reviewers (2019-2020)
Excellent Editors of ASM (mBio), Springer Nature and Frontiers.
Faculty of Pharmacy, The University of Lahore, PakistanNano-Drug Delivery; Drug Metabolism and Pharmacokinetics; Anticancer Drug Targeting; Pharmaceutical Analysis; Gene Delivery
Associate Professor at The University of Lahore, Punjab, Pakistan.
Dr. Afzal got her Ph.D. degree from China Pharmaceutical University (CPU) and has expertise in advanced mass spectrometry such as LC/MS-IT/TOF and analytical techniques like HPLC, UV, FTIR, and Fluorescence Spectrophotometer. She is one of the pioneer scholars to develop pest-containing nuclear protein (PCNP) based therapeutics. During her presentation, she highlighted the potential of PCNP protein as a novel target in cancer therapy.
Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”,Naples, ItalyCellular Senescence; Radiation Therapy; Stem Cells; Cell Cycle
Member of Stem Cell Research Italy (SCR Italy)
Postdoctoral fellowship in Molecular Biology at the School of Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy
Young Researcher at Human Health Foundation Onlus. Philadelphia, PA, USA (2007/2008)
Researcher at CNR (National Research Council), Napoli, Italy (2012/2013 )
Postdoctoral fellowship at University of Campania, Napoli, Italy (2013/2017)
Visiting Researcher at CNIO, Madrid, Spain (2013)
Visiting Researcher at GENEKOK, Kayseri, Turkey (2014)
Visiting Researcher at Tohoku University, Sendai, Japan (2015)
Visiting Researcher at CEA, Fontenay-aux-Roses, France (2017)
Department of Health Sciences, Magna Graecia University of Catanzaro, Catanzaro, ItalyAcute Kidney Injury; Renal Failure; Nephrotoxicity; Experimental Nephrology
Full Professor of Nephrology at the Department of Health Sciences, "Magna Græcia" University, Catanzaro, Italy.
Awarded at several national and international nephrology congresses. Prof. Andreucci has more than 200 publications in international, peer-reviewed scientific journals with an h index factor of 42 and more than 5100 citations to his work
Department of Biology, Tor Vergata University of Rome, Rome, ItalyMolecular Mechanisms of Neurodegeneration; Amyotrophic Lateral Sclerosis; Neuroinflammation; Microglia; Fibrosis; Astrocytes; Animal Models of Neurodegenerative Diseases; Purinergic Signaling; Histaminergic Signaling; Neuropharmacology
Senior Researcher at University of Rome Tor Vergata.
After a degree in Pharmacy at Sapienza University of Rome, Dr. Apolloni attained Master degree in “Clinical Trials” and in “Organic Chemistry of Natural “ at Sapienza University. Dr. Apolloni has obtained her PhD in Neuroscience at University of Tor Vergata, working in the Cellular Neurobiology Laboratory at Fondazione Santa Lucia/IBCN-CNR in Rome, Italy. Dr. Apolloni has proven experience in cellular neurobiology and neuropharmacology research, with particular emphasis on in vivo and in vitro models. During postdoctoral research, her work was focused on the ALS field, and mainly on the role of extracellular ATP in ALS models. Recent interests are the pathological role that neuroinflammation plays in ALS and the pharmacological and molecular characterization of microglia-mediated signaling sustaining neurodegeneration.
Department of Life and Environmental Sciences, Marche Polytechnic University, Via Brecce Bianche, Ancona, ItalyLipoproteins; Antioxidant Activity; Reactive Oxygen Species; Inflammation; Oxidative Stress; Metabolic Syndrome; Antioxidants;Nutrition; Cardiology; Atherosclerosis
Prof. Bachetti currently works at the Laboratory of developmental Neurobiology, University of Genova, Italy and in UOSD Laboratory of Genetics and Genomic of Rare Diseases in IRCCS Istituto G. Gaslini, where she have worked several years. Her main research field is molecular genetics of neurodevelopmental disorders.
Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, United StatesPsychiatry; Neuroimaging; Molecular Imaging; Addiction Psychiatry; Cognitive; Memory; Consciousness; Brain; Prefrontal Cortex; Genetic Addiction Risk Severity
Professor and Chief of Psychiatry at the VA at The University of Texas Health Science Center at San Antonio.
Prof. Badgaiyan, MD, is a psychiatrist and cognitive neuroscientist. He is Chairman of the Department of Psychiatry and Behavioral Sciences at Richmond University Medical Center, and Professor of Psychiatry at Icahn School of Medicine at Mount Sinai in New York. He received formal training in psychiatry, psychology, cognitive neuroscience, molecular imaging and neuroimaging. He was awarded the prestigious BK Anand National Research Prize in India and Solomon Award of Harvard Medical School. His research is focused on the study of neural and neurochemical mechanisms that control human brain functions. He developed the single scan dynamic molecular imaging technique (SDMIT) to detect, map, and measure neurotransmitters released acutely in the human brain during task performance. This technique is now used in laboratories all over the world. Using this technique, he studies dopaminergic control of human cognition and behavior. He is also interested in learning the nature of dysregulated dopamine neurotransmission in psychiatric and neuropsychiatric conditions. His research is funded by NIMH, NINDS, VA, and various foundations. Previously he served in the faculty of Harvard Medical School, SUNY Buffalo and University of Minnesota. He has published extensively in peer-reviewed journals.
School of Medical and Health Science. Edith Cowan University, Perth, AustraliaDiabetes; Genetics; Complications of Diabetes
Associate Professor in the School of Medical and Health Sciences and the Centre for Precision Health
Researcher and Associate Professor at ECU
Research officer at the Harry Perkins Institute of Medical Research
Research Advisor to the Nathan Centre for Rare Disease
Member, Australian Society for Medical Research (ASMR)
Member, Australian Diabetes Society (ADS)
Member, Women in Technology WA (WiTWA)
Member, Science Teachers Association of Western Australia (STAWA)
Member, Australian Society for Medical Research (ASBMB)
Member, Higher Education Research and Development Society of Australasia (HERDSA)
Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, University of Firenze, Firenze, ItalyThrombosis; Fibrinogen; Oxidative Stress; Protein Structure
Department of Pharmacology and Medical Recipes of Zaporozhye State Medical University, UkraineLipid Peroxidation; Free Radicals; Antioxidants; Reactive Oxygen Species; Oxidative Stress Biomarkers; Antioxidant Activity; SOD; Free Radical Scavengers; Biomarkers; Inflammatory Biomarkers
Professor and Head of Department at Zaporizhia State Medical and Pharmaceutical University.
Education: Graduated from Zaporizhzhia State Medical Institute (1988).
Position: postgraduate student (1988), professor assistant (1991), senior teacher (1999) Department of Physiology, associated professor (2004), professor (2006), head of the Department of Pharmacology and Medicinal Preparation (from 2005). Main scientific researcher of «Pharmatrone» (since 1993).
Research focus: molecular and biochemical mechanisms of ischemic brain damage and development of effective neuroprotectors. Role of reactive oxygen and nitrogen species, thiol-disulfide system, pro-/anti-apoptotic proteins, estrogen receptors, factors of endogenous neuroprotection, chaperones in mechanisms of death/survival of neurons; search and study of drugs for treatment of CNS pathologies; search of effective neuro- or cardioprotectors among derivatives of 1,2,4-triazole, chinazoline, xanthine.
Scientific achievements: author and co-author of 715 scientific works, 182 patents of Ukraine and Russian Federation, consulted preparation of 2 Dr.Hab and 12 Ph.D., scientific supervisor of 3 Dr. Hab and 7 Ph.D. thesis. Participated in the creation of original drugs Thiotriazoline, Thiotriazoline-forte, Thiocetam, Thiocetam-forte, Thiodarone, Carbotril,. Head of laboratory of preclinical research of medicines at ZSMU; head of Zaporizhzhia section of Association of pharmacologists of Ukraine. Co-worker of regional group of National expert centre of Ministry of Health of Ukraine.
Prizes: token of the Bibliographical Society of America (2003); prizewinner of «Scientific research of the year» nomination of regional program «Zoryaniy shlyah» (2000). Prizewinner of premium of Cabinet of Ministers of Ukraine (2017).
Monographs:
1. Metabolitotropic drugs AML. Association of Medical Literature CJSC: Moscow, 2007. -304 p. [in Russian]
2. Magnesium-containing drugs: pharmacological properties, application. Zaporizhzhia, Kyiv: ZSMU, 2007. -124 p. [in Ukranian]
3. Rational neuroprotection. Donetsk: Zaslavsky Publishing House, 2008. -264 p. [in Russian]
4. Neuropharmacology of riluzole Dnipropetrovsk: RVA "Dnipro-VAL", 2011. -164 p. [in Ukranian]
5. Thiotriazolin, thiodarone in the treatment of cardiovascular pathology. Zaporizhzhia: Printed World, 2011.- 305 p. [in Russian]
6. Neuroprotection and neuroplasticity. Kyiv: Logos.-2015. -512 p. [in Russian]
7. Thiol-disulfide system: role in endogenous cyto- and organoprotection, pharmacological modulation pathways. Kyiv: Yuston Publishing House LLC 2020. [in Russian]
8. Perinatal lesions of the nervous system. Zaporizhzhia: Education, 2020. -364p. [in Ukranian]
Textbooks:
1. Side effects of drugs. «New Book» Publishing House, Vinnytsia, 2021. -537p.
2. Pharmacology with the basics of pathology. «New Book» Publishing House, Vinnytsia, 2020. -537p. ISBN: 2267
3. Pharmacology. «New Book» Publishing House, Vinnytsia, 2020.-632p. ISBN: 978.-966-382-840-4
Department of Chemistry, Cleveland State University, Cleveland, United StatesCancer Chemotherapy; DNA Damaging Agents; DNA Polymerases; Nucleoside Analogs; DNA Repair; DNA Damage Response; Leukemia; Glioblastoma Multiforme
NEUROFARBA Department, Pharmaceutical and Nutraceutical Section, Laboratory of Molecular Modeling Cheminformatics & QSAR, University of Florence, Florence, ItalyMedicinal Chemistry; Drug Design; Carbonic Anhydrase; Enzymology; Molecular Modeling
PhD; Research fellow at University of Florence
Dr. Bonardi, PhD Post-Doctorate Fellow at the NEUROFARBA Department, University of Florence, Italy. Degree in Pharmaceutical Chemistry and Technology in 2016, PhD cum laude in Medicinal Chemistry in 2021 from the University of Florence, Italy. Alessandro Bonardi developed multidisciplinary expertise, falling in SSD CHIM/08, in: 1. Rational design and synthesis of small molecules of pharmaceutical interest. His main research topics are the metalloenzymes carbonic anhydrases (CAs) and the discovery of modulators for biomedical purposes. He achieved excellent knowledge of organic chemistry used for the synthesis of a multitude of CA inhibitory scaffolds and molecular hybrids. 2. In silico structure-based drug design and study of the action mechanisms of small molecules toward their biological target. He has a documented experience in the use of computational chemistry, bioinformatics and molecular graphics for the computationally driven design of bioactive molecules and for deciphering their mechanism of action, adopting a plethora of molecular modeling techniques. 3. In vitro studies for the biological evaluation of the inhibitors/activators activity on CA isoforms, using the stopped-flow kinetic technique. He also performed the activity characterization of new CAs and spectrophotometry studies to detect CA-catalyzed reactions.
Maggiore “Nino Baglieri” Hospital - ASP Ragusa, Modica (RG), ItalyLaboratory Medicine; Molecular Biology; Biochemistry; Neurobiology; Clinical Biochemistry; Microbiology
Post-Doctorate, Researcher, University Hospital Polyclinic Vittorio Emanuele, Catania, Italy
Editorial Board Member (Review Editor) of Frontiers in Pharmacology
Editorial Board Member of “Peertechz Journal of Cytology and Pathology“
Editorial Board Member of “International Journal of Neurology Research”
Reviewer of Frontiers in Pharmacology, section Experimental Pharmacology and Drug Discovery, Plos One, Neurochemical Research, Neural Regeneration Research
Department of Biomedicine, Neuroscience and advanced Diagnostics (BIND), University of Palermo, Palermo, ItalyBrain Stimulation; Cognitive Sciences; Headaches and pain; Neuromuscular Diseases
Associate Professor of Neurology of University of Palermo, Palermo (UNIPA) .
Prof. Brighina MD, board certified neurologist, associate professor of neurology at University of Palermo, Italy, chief of the Center for the Study of the Headaches, rhe center for the study of rare neuromuscular disease and the Unit of Neurophysiopathology (clinical electrophysiology,and non invasive brain stimulation techniques) at the University Hospital Policlinico of Palermo, Italy.
Principal research interests: headache and clinical neurophysiology with particular respect to techniques of not invasive brain stimulation like transcranial magnetic stimulation (TMS) and transcranial electrical stimulation (tES), applied to explore pathophysiology and also potential alternative treatment strategies of neurological and psychiatric diseases. Filippo Brighina performed NIBS studies on neglect, aphasia, chronic pain but the principal target of his research, especially in last years was migraine. He particularly explored pathophysiological mechanisms specifically investigating the role of abnormal cortical excitability as a critical factor underlying attacks precipitation and chronification of the disease.
More recenly, his interest moved also to rare neuromuscular diseases with particular reference to treatable rare genetic disease (hereditary transtiretin amiloidosis).
He authored 198 publications on ISI journal and presented about 200 papers at national and international meetings; he has been member of the executive board of the Italian Society for the study of Headache (SISC) and Italian Society of Psychophysiology (SIPF). He is also member of the editorial board of the following journals: Frontiers in Human Neurosciences, Pain Research and Management (associate editor), BMC neurology (associate editor), Brain Science (associate editor). He’s also ad hoc referee of many scientific high impact ISI journals (Brain, Cephalalgia, Cerebellum, Clin Neurophysiol, Europ J Neurosci, Headache, J Pain, J Neurosci, Cortex, Neuropsychologia, Pain etc) and performed reviews of research project for MIUR (Ministry of Italian University and Research) and SNSF (Swisse National Science Foundation).
1. Klinisk Genetik, Vejle Sygehus, Department of Clinical Genetics, Lillebaelt Hospital,Vejle, Denmark;
2. Institute for Regional Health Services, University of Southern Denmark, Odense, DenmarkMolecular Genetics; Molecular Biology
Professor, IRS - Lillebælt Hospital, Research Unit of Human Genetics (Vejle)
Founder of Amplexa Genetics A/S
Senior researcher, Department of Clinical Genetics, Odense University Hospital, Odense.
Associate professor, Institute of Health, University of Southern Denmark
Visiting Professor, Near East University, Faculty of Medicine, Department of Medical Genetics, Nicosia, Cyprus
Editor on PlosOne (more than 100 manuscripts) and Advances in Endocrinology, ContROL– Genetics
Review for PlosOne, Lipidology, European Journal of Endocrinology, SciTechnol, BioMed Central, Clinical Biochemistry, Frontiers in Genetics, Clinical Biochemistry, Frontiers in Genetics, SciTecTool.
Member of the National Genom Center Advisory board on Endocrinology, EndoGenNet.
Member of the National Genom Center Advisory board on interpretation.
CRN Genetics Workstream and CRN Council, the CHI Collaborative Research Network (CRN)
Member of Illumina sequencing expert panel, Nordic Alliance for Clinical Genomics (NACG), Danish Sociaty of Clinical Academics (DSKA), Danish Sociaty of Clinical Genetecist (DSMG), Odense Pancreas Center (OPAC)
Department of Neuroscience, Reproductive and Odontostomatological Sciences-ENT Section, University of Naples “Federico II”, Naples, ItalyRhinology; Laryngology; Rhinology; Biologics; Head and Neck Oncology; Chemical Sense; Neuroimaging; Pediatric Otorhinolaryngology; Head and Neck Surgery; Otorhinolaryngology; Personalized Medicine
Associate professor at the University of Naples Federico II in Naples, Italy.
Prof. Cantone, MD, PhD, is an associate professor at the University of Naples Federico II in Naples, Italy. As an ear, nose and throat physician, her clinical interests include rhinology, otology, allergology, smell and taste disorders and nasal cytology. After earning her degree in medicine and surgery from the University of Naples Federico II, Dr. Cantone continued her medical training there, specializing in otorhinolaryngology. She later acquired a master’s in nasal cytology and in rhinoallergology from the university and subsequently went on to also earn a PhD in molecular pathology and pathophysiology. Dr. Cantone’s areas of research include chronic rhinosinusitis and chemosensory research. She is currently a member of the International Global Consortium for Chemosensory Research, which conducts scientific studies to determine the possible effects of respiratory illnesses on smell and taste. She is the author of numerous publications in national and international medical journals.
Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, Henan, ChinamRNA Decay; Cloning; Sequencing; RNA
Ph.D, Professor at Zhengzhou University, Zhengzhou, China.
Dr. Cao is a Professor at the Zhengzhou Central Hospital Affiliated Zhengzhou University, Zhengzhou, China. Dr. Cao’s research is committed to the diagnosis and treatment of esophageal squamous cell carcinoma (ESCC) and made progress in identifying the genomic and epigenetic driver to improve its prognosis. Dr. Cao has contributed peer-reviewed publications in many journals such as《npj Precision Oncology, 2022》、《journal of environmental sciences, 2022》、《Journal of Experimental & Clinical Cancer Research, 2021》、《Nature Communications, 2020》、《Cancer letters, 2020》、《J Cancer Res Clin Oncol, 2020》、《Am J Transl Res. 2019》、《Chinese journal of Oncology, 2018》、《Oncotarget, 2018》、《Cancer Science, 2018》、《Front. Pharmacol., 2017》、《Oncogenesis , 2015》、《BMC Cancer, 2015》、《British Journal of Dermatology，2013》. Dr. Cao earned his Ph.D. in the Oncology from the Cancer Institute at Zhejiang University, China, and received a postdoctoral training fellowship in the Molecular/Genetic Epidemiology of Cancer Program at UCLA. Dr. Cao has earned numerous awards and distinctions, including SPORE Lung Cancer Fellowship Award from the National Institutes of Health, National Nature Science Foundation Award, Henan Natural Science Foundation Award.
Institute of Bioenergetics, Biomembranes and Molecular Biotechnologies (IBIOM) at National Research Council (CNR), Rome, Italyp53; p53 Gene Family; Cancer; Tumor Suppression; Transcriptomics; NGS, Transcriptional Regulaion; microRNAs; ncRNAs
Professor at the Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies.
Imperial College London, Department of Surgery and Cancer, London, United KingdomNon-coding; Transcription; miRNA; lncRNA; Cancer Regulation
Dr Leandro Castellano obtained his Master Degree in Biology in Biology at the University of Salento, Italy. He then moved to Rome at the University “La Sapienza” where he completed a PhD in Human Biology and Genetics (2003-2007) working during the first year on the role of Post Transcriptional Gene Silencing (PTGS) in the Circadian Rhythm of the filamentous fungus Neurospora Crassa and later, on the role of microRNAs in human Cell Cycle and in Chronic Lymphocytic Leukaemia (CLL).
He moved to Imperial College London in 2007 where he worked as a Research Associate focusing on the role of microRNAs in epithelial cancers. From 2011 he was appointed as Team Leader at the Division of Surgery and cancer, at Imperial, where he directly supervised several PhD students, Research Associates and Research Assistants. During these years Dr Castellano research interests expanded from microRNAs to the role of various classes of short and long non-coding RNAs in epithelial cancer development and progression.
He is the Head of Department of Biochemistry and Biomedicine and a Reader (Associate Professor) in RNA Biology at the University of Sussex and holds an honorary position at Imperial College London as visiting Reader.
He is the co-Director of the Sussex RNA Research Centre (https://www.bsms.ac.uk/research/clinical-and-experimental-medicine/rna-biology-research-group/index.aspx)
He is the Designated Individual (DI) under the Human Tissue Act at the School of Life Sciences at the University of Sussex.
He is a fellow of the higher education academy (FHEA).
For more information about our research see the Castellano Lab website:
https://www.sussex.ac.uk/research/labs/castellano-lab/
Editorial Board
- Associate Editor, “Oncogene” (Springer Nature)
- Associate Editor "Cancer Gene Therapy" (Springer Nature)
- Editorial Board "Non-coding RNA" (MDPI)
- Editorial Board, “Non-coding RNA Research” (KeAi publishing, Elsevier)
School of Basic Medical Sciences, Henan University School of Medicine, Kaifeng, ChinaEpigenetics and Metabolisms
Professor at the School of Basic Medical Sciences, Henan University.
Mainly engaged in research on medical molecular and cell biology, focusing on "epigenetic regulatory mechanisms of major diseases and important life processes", "new non-autophagic functions of autophagy-related proteins", "protein quality control mechanisms of important proteins" and other fields. As the corresponding author, he has published more than 20 papers in journals such as Developmental Cell, Autophagy, Cell Death and Differentiation, EMBO Reports, and Nucleic Acids Research.
Department of Physics, The University of Texas at Arlington, Arlington, United StatesNanomaterials; Nanomedicine; Cancer nanotechnology
Professor of Physics, The University of Texas at Arlington.
Education:
Ph. D. in Chemistry, 1992, Peking University, Beijing, China
MS in Crystallography, 1988, Central South University, Changsha, China
BS in Mineral Chemistry, 1985, College of Earth Science, Jilin University, Changchun, China
Awards:
Distinguished young scientist award by the Chinese Academy of Sciences, 1997
Honor award for the distinguished achievement in Science & Technology by State Education Commission of China, 1995
Honor award for the achievement in Science & Technology by Peking University,1994
Research Excellent Award, University of Texas at Arlington, 2008, 2009, 2010
Department of Clinical Oncology, Queen Elizabeth Hospital, Hong Kong, ChinaGenomics; Proteomics; Drug repurposing; Bioinformatics; Next-generation sequencing; Cancer biomarker; Evidence-based medicine; Extracellular vesicles; MicroRNA; Molecular diagnostics; Non-coding RNAs; Nasopharyngeal carcinoma; Non-small cell lung cancer
Dr. William Cho is a biomedical scientist at the Department of Clinical Oncology, Queen Elizabeth Hospital in Hong Kong. With a strong background in cancer biomarker discovery and translational research, Dr. Cho has published extensively in peer-reviewed journals. His research interests include genomics, proteomics, and liquid biopsy in oncology. He actively serves on editorial boards and is a frequent reviewer for international scientific journals.
Department of Biology, Ecology and Earth Sciences, University of Calabria, Rende, ItalyGenetic Variability; Polymorphisms; Aging and Longevity; Complex Traits; Telomere; Healthy Aging; Genetic Epidemiology; Association Studies
Paolina Crocco (PC) has been a researcher in Genetics (BIOS-14/A - ex BIO/18) since October 2022. PC obtained her Master's Degree in Biological Sciences, Summa cum laude (2006) and her PhD in "Molecular Bio-pathology" at the University of Calabria (2010). From 2011 to 2021, she participated in the research activities of the UNICAL Genetics Laboratory, also taking part in several European projects aimed at investigating the determinants of human longevity. She currently teaches the “Genetics” course for the Bachelor of Science in Biological Sciences and the “Applied Human Genetics” course for the Bachelor of Science in Health Biotechnology. PC is co-relator for several Bachelor's and Master's theses in Biological Sciences and Biotechnology.
PC is involved in the study of genetic and epigenetic variability in ageing, human longevity and age-related phenotypes. PC has co-authored papers in international journals and numerous conference presentations. PC is a referee for international journals in the field of her research, including Cells, Genes, Frontiers in Medicine, Biomolecules, Life, International Journal of Molecular Sciences, International Journal of Environmental Research and Public Health. PC is a member of the editorial board of journals such as Frontiers in Genetics (Associate Editor in Genetics of Aging and Review Editor in Genetics, Genomics and Epigenomics of Aging - Cancer Genetics and Oncogenomic), Frontiers in Molecular Biosciences (Associate Editor in Molecular Diagnostics and Therapeutics) and Gene & Protein in Disease and guest editor of special issues for the International Journal of Molecular Sciences, Biology and Genes.
PC is a member of AGI (Italian Genetic Association) and of the Order of Italian Biologists (since 2008).
PC is an elected member of the Board of the Department of Biology Ecology, Earth Sciences, University of Calabria - triennium 2022/2025.
Since February 2025 PC has been a member of the Doctoral Teaching Commission in Life science and Technology at the University of Calabria.
Since November 2024 PC has been the delegate for incoming and ongoing orientation for the Department of Biology, Ecology and Earth Sciences, University of Calabria and for the Biology and Biotechnology undergraduate and postgraduate degree courses.
Since 2023 PC is member of the teaching board of the PhD programme ‘Life Science and Technology’ of DiBEST, University of Calabria
Since 2022 PC is Co-referee for the University of Calabria of the PLS in Biology and Biotechnology A.A. 2022/2025
From March 2023 to November 2023 PC is a reference lecturer for students with disabilities and DSA appointed by the Director of the Department of Biology Ecology, Earth Sciences, University of Calabria.
Institute of Nano Biomedicine and Engineering, Department of Instrument Science and Engineering, School of Electronic Information and Electrical Engineering, Shanghai Jiao Tong University, Shanghai, ChinaNano Functional Materials; Nano Image Probes; Intelligent Diagnosis and Treatment Instruments; Gastric Cancer Early Warning and Early Theranostics System; Nano Therapy Technology Development and Transformation
Distinguished professor of Shanghai Jiaotong University, Shanghai, China.
Dr. Cui is currently a distinguished professor of Shanghai Jiaotong University, vice dean of Translational Medicine Research Institute of Shanghai Jiaotong University, the head of the Nano-Biotechnology Research Institute, Assistant Dean of the Institute of Micro-and Nano-technology, PhD supervisor, Deputy Director of the key laboratory of thin-film micro-technology, winner of the National Fund for distinguished young scholars, and Chief Scientist of Nano major scientific research projects. His research fields are nano-material synthesis, biological effects and safety evaluation, multifunctional nano-probes and molecular imaging.
Department of Anesthesiology, Washington University in St. Louis, St. Louis Missouri, United StatesMembrane Proteins; Lon Channels; X-Ray Crystallography; Cryo-electron Microscopy; Structural Biology; Structural Bioinformatics; Structure-based Drug Designin; Virtual Screening; Pharmacophore Modeling
Department of Ophthalmology, Henan University of Science and Technology, Sanmenxia, ChinaEye Disease; Outflow Tract; Ophthalmology; Glaucoma
Medical Doctor (MD), Postdoctoral Fellow at the University of Pittsburgh, USA; Associate Chief Physician; Senior Engineer; Master’s Thesis Supervisor.
Currently serves as a Party Committee Member and Vice President of Sanmenxia Central Hospital, Dean of Sanmenxia Eye Hospital, and Dean of Sanmenxia Institute of Ophthalmology.
Recipient of the Henan Provincial Government Special Allowance Expert Award; Henan Provincial Academic and Technical Leader; Henan Outstanding Talent; Henan May 4th Youth Medal; Sanmenxia Municipal Model Worker; Sanmenxia May 1st Labor Medal Recipient; Sanmenxia Leading Talent; Sanmenxia Outstanding Talent; Xiaohan Master Craftsman; and Sanmenxia Good Person (Community Recognition).
Department of Pharmacy, University of Pisa, Pisa, ItalyIntracellular Pathways; Epigenetic Regulation; Neurodegenerative Disease-related Proteins
Associate Professor in Molecular Biology at the Dept. of Pharmacy, University of Pisa, Italy.
Dr. Simona Daniele (SD) is an associate professor in Molecular Biology at the Dept. of Pharmacy, University of Pisa, Italy. She gained a Phd in Science of Drug and Bioactive Substances in 2011. From 2012 to 2016 she won Post-doc positions in Biochemistry and Molecular Biology at University of Pisa, University of Milan and at the Italian Institute of Technology. From 2016 to 2019, she worked as a senior researcher in Molecular Biology at University of Pisa.
The research activity is proven by more than one hundred papers published in prestigious international journals, mainly dealing with intracellular pathways and protein aggregation. SD has had the opportunity to work in laboratories in Pisa, Genoa, Milan, Barcellona and Bethesda where she has mastered a number of different biological and cellular techniques.
From 2009 to present, SD has been involved in several projects concerning molecular and intracellular signalling pathways related to neurodegenerative and neurodevelopmental diseases, as well as in the molecular characterization of innovative drugs. She has developed and set-up of immunoenzymatic assay to detect protein hetero-complexes, including p53 ones, and protein aggregates. She has a great expertise in the development of biological tests for target-verifying of new compounds, cell culture, isolation of stem cells from cell lines and tissues, stem cell differentiation and study of intracellular pathways. In the last years, she has developed new skills in managing biological samples derived from patients and in analysing clinical data.
Pelé Pequeno Príncipe Research Institute, Cell Therapy and Biotechnology in Regenerative Medicine Research Group, Curitiba, BrazilCardiomyopathies; Hematopoietic Mesenchymal Cells; Adipose-Derived Mesenchymal Stems; Exosomes; miRNAs; Cardiac Regeneration; Cardiac Protection and Cardiac Remodeling
Faculty of Medical Sciences of Minas Gerais (1984); pediatrician and neurologist (adults and children), University of São Paulo (USP), Brazil (1987); Specialisation in biology, pathology and neuromuscular development, Université Paris VII and Pitié Salpêtrière Hospital, France, Ph.D. 1988 to 1991; Master of Science (MSC) in neurology, USP (1994) and Ph.D. in Biotechnological Process Engineering, Federal University of Paraná (UFPR), Brazil (2006). From 2001 to 2008, ahead of the Experimental Preclinical Laboratory Research on stem cell therapy and translation at the The Pontifical Catholic University of Paraná. From 2006 to the present as been ahead of the “Cell Therapy and Biotechnology in Regenerative Medicine.” Research Group at the Pelé Pequeno Príncipe Institute, Professor of Pelé Pequeno Príncipe Faculty, Supervisor of the MSc and Ph.D., Curitiba, Paraná, Brazil. Ex-Associate Professor Biotechnological Process Engineering in UFPR, and during that time, I supervised MSc and Ph.D. students. Developed research on a preclinical model with coculture of myoblasts and in vitro bone marrow mesenchymal stem cells, followed by a preclinical model in ischemic myocardial and Chagas Disease. In 2003, responsible for the isolation and culture proceedings for Phase I for cellular therapy in chronic ischemic cardiomyopathy at the Laboratory for the Study of Human Cells and the clinical Phase II concerning the isolation of mononuclear cells from human bone marrow; both of which were autologous models. Since 2006, concentrated on developing stem cell research in neuroscience for neurodegenerative/neuromuscular diseases, focusing on the following topics:
· Preclinical and Clinical Research
· Basic Science of Stem Cells and related Stem Cell Therapy research;
· Cardiomyopathies;
· Central Nervous regeneration, particularly Parkinson's disease; Alzheimer's disease; motor neuron diseases (spinal cord trauma and lateral amyotrophic sclerosis); ischemic encephalopathies;
· Neuro-Immunological Diseases: Multiple Sclerosis;
· Neuromuscular Diseases: myopathies.
Also acts in developing research on advanced therapy and cellular biotechnology and biocompatible nanotechnology matrices/nanotherapeutics products within the Brazilian Nanobiotechnology Network, funded in 2008 by the Coordination for the Improvement of Higher Education Personnel (Capes). In the area of nanotechnology, have developed studies on nanostructured cellulose matrix and other areas, including the following: the use of matrix as a scaffold for skin and the heart using a patch for the transmission of cells and drugs; the development of nanoparticles to deliver drugs in Parkinson’s disease based on nanostructured implants for cellular therapy. Technical knowledge regarding mammalian cells, particularly human stem cells from bone marrow, umbilical cord blood, adipose and murine tissue, cells from bone marrow and adipose tissue for isolation, cultivation, expansion, characterization, and cryopreservation; phenotypic and genotypic characterization; exosomes derived-mesenchymal stems and miRNAs; the development of preclinical models on the effects of cell and their products on therapy and drug therapy; and in vitro and in vivo cytotoxicity studies in researching and developing new therapeutic approaches based on preclinical for translation, there are questions related to safety: from manufacturing to gene stability and the potential of stem cells from different origins and their characteristics about isolation, characterization, cryopreservation, and cultivation.
These issues resulted in publications, and the results of the preclinical studies were successfully translated—editor and reviewer for international scientific journals. Since 2008, I have been a member of the European Society of Artificial Organs (ESAO) and the International Parkinson and Movement Disorders Society. Since 2008, I have submitted the researcher results at international conferences hosted by ESAO, BioNanomed and, CardioBioAssist. Member of the Human Ethical Committee at the Pequeno Príncipe Faculty and Coordinator of the Experimental Use of Animals Committee at the Pequeno Príncipe Complex.
Department of Medicine and Health Sciences, University of Molise, Campobasso, ItalyCell Biology; Prostate Cancer; Breast Cancer; PRDM Gene Family
Dr. Erika Di Zazzo works in the Department of Medicine and Health Science at the University of Molise in Campobasso, Italy. She is also the Adjunct Professor at the University of Campania "Luigi Vanvitelli" in Caserta, Italy. Her research interests mainly focus on PRDM genes, cancers, signal transduction, cancer, the cell cycle, apoptosis, androgens, estrogens, prostate cancer, breast cancer, oxidative stress, steroid receptors, and testicular germ cell tumors. She is a Topical Advisory Panel Member of IJMS. She is also the reviewer for the following journals: Applied Sciences, Clinical & Translational Oncology, International Journal of Molecular Sciences, Journal of Personalized Medicine, Marine Drugs, and Molecules.
Department of Pathology, National University of Singapore, SingaporeCancer Immunotherapy; Targeted Therapy; Cancer Vaccine; Cancer Genome; cfDNA Methylome and Cancer Screening
Research Assistant Professor in the field of Pathology.
The research interests of the applicant focus on two critical areas in cancer research: developing innovative therapeutic approaches to overcome resistance to cancer immunotherapy; and identifying genetic and epigenetic abnormalities in cancers and pre-cancers. He has authored 71 manuscripts in international journals, over half of them were published in journals with impact factor >10. He also served as an invited ad hoc reviewer and reviewed over 440 manuscripts for 131 international journals. Over the past two years, he has successfully secured more than 2.2 million SGD in research funding as the Principal Investigator (PI), and 3.5 million SGD as Co-Investigator and Collaborator. He also contributes as a Team Principal Investigator to a large CRP (Competitive Research Programme) grant from NRF. He was the recipient of the prestigious Lee Kuan Yew Postdoctoral Fellowship and the Year 2021 Gilead Research Scholars Award (Hematology and Oncology).
Faculty of Medicine, University of Medicine and Pharmacy “Carol Davila”, Bucuresti, RomaniaIschemic Heart Disease; Atherosclerosis; Molecular Mechanisms of Acute coronary Syndromes; Arterial Hypertension; Hypertensive Target Organ Damage
Maria DOROBANTU, MD, PhD, FESC, FACC Emeritus Professor at the University of Medicine and Pharmacy Carol Davila Bucharest Past Chair of the WG6 of ESC (Chair 2016-2018) Ex officio member of the Board of ESH, (Representative with National Societies) from 2019 Member of the ESH Board as a Representative of the National Societies of Hypertension (2019-2021 ) President of ISH RAG Europe(since 2024) Corresponding Member of the Romanian Academy Associate Member of National Academy of Medicine, France Member of the Romanian Academy of Medical Sciences Member of the Academia Europaea My special fields are Microcirculation, ACS and Hypertension Publications in these fields in EHJ, IJC, JH, Lancet, NEJM, Echocardiogragy, RJC, JHR, etc Books in Springer Publishing House as co-edithor (Hypertension and HF, Microcirculation, New Insights in HF, etc) in Romanian Academy Publishing House (5 books one awarded with the Romanian Academy Prise) Medical Publishing House, etc HIRSCH Index 46 (21,113 citat
Center for Human and Molecular Genetics, Universidade Federal do Espírito Santo, Espírito Santo, BrazilCancer Genetics; Tumor Markers; Genotyping; Genetic Identification; Forensic DNA; Population Genetics
Associate Professor at Universidade Federal do Espírito Santo, Brazil.
Dr. Louro is a physician and graduate of the Federal University of Espírito Santo. He completed his doctorate in Biochemistry and Molecular Genetics at the University of Alabama at Birmingham and his postdoctoral fellowship in Molecular Genetics of Cancer. He worked at the University of Alabama at Birmingham as a Research Associate and as Director of the Comprehensive Cancer Center Microarray Facility. He is a Full Professor at the Federal University of Espírito Santo. He works in the area of Human and Molecular Genetics, with an emphasis on genetic markers, molecular diagnostics, genetic identification, oncogenetics, the genetics of infectious diseases such as COVID-19 and arboviruses, the genetics of insects and crop pests, and forensic genetics. He is an advisor in the Master's and Doctoral programs in Biotechnology. He has collaborated and continues to collaborate with several international groups, including the University of California, Berkeley, the California Academy of Sciences, the University of Louisville, Mongantown University, Harvard University, John's Hopkins University, The University of Texas MD Anderson Cancer Center, and the Zoologische Staatssammlung München in Germany.
Nutrigenomics and Growth Biology Laboratory, Washington State University, Pullman, United StatesNutrigenomics; Stem cell; Adipose and Muscle Development; Obesity and Diabetes; Exercise
Regents Professor and Endowed (Funded) Chair in Nutrigenomics and Growth Biology, Department of Animal Sciences, Washington State University, Pullman, WA.
AWARDS, HONORS AND OTHER EXPERIENCES:
- Elected to the Washington State Academy of Sciences, 2024.
- Regents Professor, Washington State University, 2023-Current.
- The American Society of Animal Science (ASAS) Award in Animal Physiology and Endocrinology, 2019.
- Faculty Excellence in Research Award, College of Agricultural, Human, and Natural Resource Sciences, WSU, 2018.
- The American Society of Animal Science (ASAS) Award in Animal Growth and Development, 2017.
- Distinguished Service Award, Physiological Genomics Group, American Physiological Society, 2017.
- Standing Member, NIH-NIDDK, (Diabetes, Endocrinology, and Metabolic Diseases B, DDK-B) Study Section (2016-2020).
- Fulbright Specialist, Institute of International Education (IIE), the U.S. Department of State, Washington, DC. 2016-2021.
- Ad hoc Member, NIH-NIAMS, Special Emphasis Grant Review Panel (ZRG1), 2009-2017.
- Invited Speaker, the Celebration of Science Week, Purdue University, West Lafayette, IN, May 9 -11, 2012.
- Early Career Achievement Award, American Society of Animal Science, 2010.
- Outstanding Advisor Award, College of Agriculture, University of Wyoming, 2008.
- Young Scientist Award, Western Section American Society of Animal Science, 2008.
- Research Award, Center for Cardiovascular Research and Alternative Medicine, University of Wyoming, 2007.
- Research Career Enhancement Award, American Physiological Society, 2006.
- Postdoctoral fellowship from the Natural Sciences and Engineering Research Council of Canada (NSERC), 2001.
- Research Excellence Award, Graduate College, Iowa State University, 2001.
- Thomas Sutherland Graduate Award for Excellence, Department of Animal Science, Iowa State University, 2001.
- Wilma D. Brewer Award for Excellence in Scientific Writing, Department of Food Science & Human Nutrition, Iowa State University, 2001.
- Verba S. And Verner H. Nielsen Scholarship Fund, Department of Food Science & Human Nutrition, Iowa State University, 2001.
- Member of national honor society of agriculture, USA: GAMMA SIGMA DELTA.
- David R. Griffith Research Excellence Award, Nutritional Sciences Council, Iowa State University, 2000.
- Ned S. & Esther Raun Graduate Scholarship, Department of Animal Science, Iowa State University, 2000.
- Ensminger Scholarship, Department of Animal Science, Iowa State University, 1999.
Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, United StatesCancer Biology; micro-RNA; Long non Coding RNA
Assisstant Professor at the University of Oklahoma Health Sciences Center.
Research activities and funding
R21CA280507 (DWIVEDI, SHAILENDRA KUMAR DHAR)May 1, 2023 - Aug 14, 2023
NIH
Role of miR-195 in Chemo-Resistant Ovarian Cancer
Role: Principal Investigator
Mazandaran University of Medical Sciences, IranStem Cell-biotechnology; Medical Biotechnology; Regenerative Medicine; Cell Therapy
Assistant Professor of Medical Biotechnology, Mazandaran University of Medical Sciences.
Dr. Enderami currently works at Mazandaran University of Medical Sciences. Their current projects are 'Pancreatic tissue engineering' and wound healing.
1.Lomonosov Moscow State University, Moscow, Russia;
2.Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Moscow, RussiaNucleosome Structure; Nucleosome-Protein Interactions; Single Molecule; spFRET Microscopy
Assistant professor, Doctor of Science
Principal research fellow (Laboratory of optical microscopy and spectroscopy of biomolecules)
Coordinator of the International Head and Neck Scientific Group, Padua, Italypromotion of international cooperation in head and neck surgery, oncology and cancer research.
Dr. Alfio Ferlito is Formerly Director of the Department of Surgical Sciences at the University of Udine School of Medicine from 2003 to 2009 and Professor and Chairman of the ENT Clinic at the same University from 1997 to 2013. He graduated in medicine at the University of Bologna in 1968. He completed his residency programme in Otolaryngology and subsequently in pathology. He worked at the ENT Department of Padua University from 1970 to 1997. Since 2009 he is the Coordinator of the International Head Neck Scientific Group.
Dr. Alfio Ferlito received many honors and awards during his career. He served as editor, co-editor, assistant editor or reviewer for the 736 journals. He has collaborated in writing articles, editorials, commentaries, letters to the editor, special issues, book chapters and books with 665 international experts. He has edited a three-volume book entitled Cancer of the Larynx (CRC Press, Boca Raton, 1985) and three other books entitled Neoplasms of the Larynx (Churchill Livingstone, Edinburgh, 1993), etc. He is Editor of four issues of ORL Journal for Oto-Rhino-Laryngology, Head and Neck Surgery. He has been author and co-author of 657 referred publications in 70 medical journals and 54 chapters in various books. He is a fellow or a member of the many societies. He collaborated as a member of the World Health Organization’s Committee on Histological Typing of Tumors of the Upper Respiratory Tract and Ear. He is also a member of the Laryngeal Cancer Association’s Committee on the Classification of Laryngeal Cancer. He was a consultant to Yale University. He was a consultant to Yale University. He has delivered prestigious lectures all over the world. In 2006 he gave the 2nd Morrison Lecture in San Francisco and the 19th Som Lecture in New York. He has divided his professional life between clinical practice, teaching and research.
School of Pharmacy, University of Camerino, Camerino (MC), ItalyEpigenetics and Neurodegeneration; Nutrigenomics; Xenobiotics and Redox System
Full Professor of Biochemistry, University of Camerino, Italy.
Prof. Rosita Gabbianelli is Full Professor in Biochemistry (BIO/10, Biochemistry) at University of Camerino, Italy from June 2021. She teaches Molecular Biology and Nutrigenomics at the Bachelor degree Course and Master degree course of Chemistry and Pharmaceutical Technology of Faculty of Pharmacy in UNICAM, Italy. Invited professor of Biochemistry at the Jilin Agricultural University, Changchun, China (from 2015). Invited Professor in Nutrigenetics and Nutrigenomics, at the University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca, Department/Unit of Food Science, CLUJ-Napoca, Romania (from 2015) and at ISS-ISEP, Porto, Portugal. Teaching activity on Nutrigenomics at University of Pharmacy-Hanoi, Vietnam, Quy Nhon University, Vietnam and Pemba, Tanzania (2017).
Prof. Rosita Gabbianelli cooperates as Guest Editor of Antioxidants, J Nutrigenet Nutrigenomics, Mech Ageing Dev, and she is a Member of review panels of several journals on health. She is Reviewer of theEuropean Commission (EX2006C200916) H2020-SC1-2019-SINGLE-STAGE-RTD, the Reprise - Register of Expert Peer Reviewers For Italian Scientific Evaluation, the STSM Cost Action NutRedOx and the Czech Science Foundation. She is Italian MC Member of DEVoTION CA18211 and HyperChildNET CA19115, and Action participant in NutRedOx CA16112 and Epichembio CM1606. Prof. Rosita Gabbianelli is the Chair of the Scientific and Organizing Committee of the European Summer School on Nutrigenomics (from 2014).
Her research field includes the study of genetic and epigenetic mechanisms associated to the development of neurodegeneration induced by early life exposure to food pesticides and nutrigenomic strategies to counterbalance neuronal damage. Her expertise is documented by 118 peer-reviewed publications, 4 book chapters and 133 abstracts to international meetings.
Università degli Studi di Roma La Sapienza, Rome, ItalyBreast Diagnostic and Interventional Imaging; Oncological Imaging; Biomarkers
Dr. Francesca Galati is a researcher and medical professional with expertise in cardiac arrhythmias and breast cancer imaging. She has a PhD in Medical Sciences and is affiliated with the University of Rome, La Sapienza. Her research focuses on the genetic mechanisms of atrial fibrillation and malignant ventricular arrhythmias, as well as breast cancer diagnosis and prognosis using MRI and other imaging techniques. Additionally, Francesca Galati, the architect, is known for her work in sustainable building design and is a consultant with FGB studio, specializing in green building certifications like LEED and WELL.
Department of Pharmacology, University of Washington, Seattle, United StatesBiophysics; Protein Aggregation ;Channelopathies;Fluorescence ;Electrophysiology ; Ion Channel Gating;In Vivo； Electrophysiology
Amsterdam UMC - University of Amsterdam, Amsterdam, NetherlandsOncology; Gene therapy; Cell therapy; Cancer research; Genomics; Transcriptomics
Team Leader Cell Therapy at the Amsterdam UMC.
Dr. Geerts currently works as Team Leader Cell Therapy at the AmsterdamUMC. He is in charge of the CAR-T programs for treating cancer patients with immune cell therapy. Dirk did academic research in Gene and Cell Therapy in Cancer and Cardiovascular Disease. He is further actively involved in Cell Biology and Genetics with many different groups worldwide.
Department of Pharmacology, University of Minnesota, Minneapolis, United StatesVirus; Structure; Biology; Cells; Biochemistry; Protein; Gene; Vaccines; Immunology
Post-Doctoral Associate, Molecular Virology Program.
Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples, ItalyBiochemistry and molecular biology of transglutaminases; Neurodegeneration; Neuroinflammation
Aristotle University of Thessaloniki, School of Pharmacy, Thessaloniki, GreeceBiologically Active Heterocycles; Thiazole; Thiazolidinone; Benzohiazole; Thiadiazoles with Antimicrobial Activity; COX/LOX; PTP1b; HIV RT Enzyme Inhibitors; Antiinflammatory
Associate Professor, Aristotelian University of Thessaloniki Greece.
Natural Products of Uzbek Academy of Science. In 1977 she defended her PhD thesis and received the Ph.D grade in Chemistry (Ph.D, Doctor of Philosophy in Chemistry). In 1984 she graduated from the School of Pharmacy of Aristotle University of Thessaloniki. From 2006-2013 she served as Head of the Department of Pharm.Chemistry. Since 2010 she has been Full Professor on Medicinal Chemistry for School of Pharmacy at Aristotle University of Thessaloniki. During 2009-2011 she was Vice President of School of Pharmacy at Aristotle University of Thessaloniki.In July 2013 Prof.Geronikaki was elected as a Full member of the Mediterranean Academy of Science and Arts.Her scientific interest is Chemistry of natural products isolation, determination of the structure; Chemistry of biologically active compounds and evaluation of their activity, using different computational methods.
Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, Arcavacata, ItalyNatural product; Cancer; Oxidative stress biomarkers; Modulatory action of nuclear receptors; Adipokines in the development and progression of breast cancer
Associate Professor at the Department of Pharmacy, Health and Nutritional Sciences, University of Calabria.
Department of Pharmaceutical Sciences, University at Buffalo, the State University of New York, New York, United StatesPolymer Synthesis; Electrospinning; Drug Delivery; Photo-Activable Prodrugs; Immunotherapy and Photodynamic Therapy
Post Doctoral Researcher at University at Buffalo, State University of New York.
With over ten years of experience in pharmaceutics, nanomedicine, and drug delivery, Dr. Giram is a Postdoctoral Associate at the State University of New York at Buffalo, where I design and characterize innovative nanoformulations for photodynamic therapy of various cancers. I collaborate with a multidisciplinary team of researchers, clinicians, and industry partners to optimize nanocarriers such as m-PEG-PLA micelles, liposomes, and LNPs that can deliver anticancer agents, immunostimulants, and prodrugs to the tumor site, enhance their therapeutic efficacy, and reduce their systemic toxicity.
I have a strong academic background and credentials, with a Ph.D. in Polymer Science and Engineering from the National Chemical Laboratory in Pune, India, and multiple publications, patents, and awards. I also received a prestigious Newton Bhabha Fellowship to conduct research at the King's College London, UK, on nanofibrous scaffolds for tissue engineering. I am passionate about advancing the field of nanomedicine and contributing to the development of safe and effective treatments for patients with cancer. As an Adjunct Professor at Dr.D.Y.PATIL INSTITUTE OF PHARMACEUTICAL SCIENCES AND RESEARCH PIMPRI, I also share my knowledge and skills with the next generation of pharmacists and scientists.
Department of Drug Design, University of Groningen, Antonius Deusinglaan, Groningen, The NetherlandsStructural Biology; Biocrystallogenesis; Infectious Diseases; Drug Design; Biophysics
Associate Professor at the Department of Drug Design, University of Groningen.
Dr. Groves received his Honours Degree in Physics from Worcester College, Oxford University, and gained his PhD from the University of London in 1999 under the supervision of Prof Tom Blundell. After post-doctoral experience in Oxford and EMBL, Heidelberg. He was appointed as an independent staff scientist at EMBL Hamburg. In 2013, he moved to the Groningen Research Institute for Pharmacy, University of Groningen and is now an associate professor. He is currently responsible for the "Medicinal Chemistry and Biophysics" course and is also involved in a Masters's program in "Molecular Medicines and Innovative Therapies" as a lecturer. His teaching disciplines include crystallography, biophysics, and infectious diseases. His research interests include structure-based drug design in human diseases, using structural, biochemical, and molecular biology to investigate disease-relevant pathways in cancer, malaria, and tuberculosis.
Wenzhou Medical University, Wenzhou, ChinaAlzheimer’s Disease; Depression; Schizophrenia; gene polymorphisms
He has published over 50 SCI-indexed international peer-reviewed research articles, with a total cumulative impact factor exceeding 150.
Jonsson Comprehensive Cancer Center, California Nanosystems Institute, Division of Oral and Systemic Health Sciences, School of Dentistry, University of California, Los Angeles, United StatesCancer; Biochemistry; Genetics and molecular Biology; Cancer metabolomics/proteomics; Cancer stem cells; Sjogren’s syndrome; Burning mouth syndrome and chronic pain
Professor at University of California, Los Angeles, United States.
Dr. Hu is a Professor and was previously the MS Program Advisor in the Division of Oral and Systemic Health Sciences at the UCLA School of Dentistry. He has managed the Oral Biology MS program since 2011. Dr. Hu is also a member of the UCLA Jonsson Comprehensive Cancer Center (JCCC) and currently serving as an editorial board member for multiple international journals. He recently edited the Cancer metabolomics: Methods and Applications for Springer Advances in Experimental Medicine and Biology book series.
Hangzhou Institute for Advance studies, University of Chinese Academy of Sciences, Beijing, ChinaMolecular Mechanism of Degenerative and Metabolic Diseases; Molecular Mechanism of Mitochondrial Homeostasis Regulation
Associate Professor at Chinese Academy of Sciences, Beijing, China.
School of Biomedical Sciences, Chinese University of Hong Kong, Hong Kong, ChinaAdipose tissue; Beige adipocytes; Chronic inflammation; Obesity; Diabetes
Prof. Hannah Xiaoyan HUI obtained her B.Sc. (First Class Honours) in Biotechnology from Shanghai Jiao Tong University and completed her Ph.D. study in Shanghai Institute of Biological Sciences, Chinese Academy of Sciences (SIBS, CAS). She then pursued her postdoctoral training at Department of Medicine, the University of Hong Kong and was later took up her post as Research Assistant Professor at the same department. In 2021, she joined the School of Biomedical Sciences, the Chinese University of Hong Kong as Assistant Professor.
The research interest of Dr. Hui lies solely on Adipose Tissue – a highly plastic organ in our body. We are using genetically engineered mouse models, primary cells/tissues and human iPS-derived adipocytes as model systems. By adopting state-of-the-art, multidisciplinary approaches, the goal of our laboratory is to understand the molecular basis of adipose tissue remodelling and its physiological relevance in obesity and cardio-metabolic diseases. Ultimately we seek to develop biomedicine that can “re-educate” the adipose tissue.
Prof. Hui is the principal investigator of research grants including General Research fund (GRF), Health and Medical Research Fund (HMRF) and NSFC (Young Excellent Scientist). Her research work has been published in top-ranked journals including Cell Metab, J Clin Invest, EMBO rep, Diabetes, Brit J Pharmacol. She also receives awards such as National Science and Technology Progress Award (2020).
Nephrology and Urology Research Center, Clinical Sciences Institute, Baqiyatallah University of Medical Sciences, Tehran, IranGenetics and Molecular Epidemiology; Cancer Biology; Epigenetics in Epidemiology; Cell Signaling; Virology; Genomic Surveillance in Public Health; Biomarker Development; Animal Models; Drug Discovery
Assistant Professor, Nephrology and Urology Research Center, University of Tehran, Iran
Department of Biochemistry and Molecular Biology, University of Rajshahi, Rajshahi, BangladeshCancer Biology; Cancer Molecular Marker; Gastrointestinal Cancers; Cancer Drug Development; Cancer Genetics, Epigenetics; Cancer Signaling
Professor in the Department of Biochemistry and Molecular Biology, University of Rajshahi, Bangladesh.
Dr. Islam has completed his undergraduate studies and MPhil in biochemistry and molecular biology at Rajshahi University, Bangladesh, and then completed his PhD in Cancer Molecular Pathology at Griffith University in the School of Medicine. Dr Islam is working on cancer biology, drug development and delivery, molecular marker development for various cancer. His has published more than 50 peer-reviewed research articles in well-reputed journals. He also wrote and published more than 7 book chapters on cancer pathogenesis and protocols with reputed publishing outlet e.g. Springer, Elsevier.
Dr. Islam was recently awarded the Chancellor's Medal for Excellence in the PhD Thesis for 2018, in recognition of his exceptional performance. He is also awarded Dean’s Award 2019, Faculty of Science, University of Rajshahi, Bangladesh for outstanding achievement in research. Dr Islam is currently working as a Post-Doctoral Research Fellow this Institute. He is also an Associate Professor (on leave) in the Department of Biochemistry and Molecular Biology at the University of Rajshahi in Bangladesh.
1. CSIR-Indian Institute of Chemical Technology, Uppal Road, Tarnaka, India;
2.Department of Biochemistry, Kakatiya Medical College, Warangal, IndiaAlzheimer's Disease; Diabetes Mellitus; Neuronal Trafficking; Therapeutic Biomolecules; COVID-19
Assistant Professor (Res.) at the Texas Tech University of Health Sciences Center (TTUHSC), Lubbock, TX, USA. Dr. Kandimalla obtained his Ph.D. in Neuroscience from Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. Dr. Kandimalla received postdoctoral fellowships from McGill University, Montreal, Canada; Emory University, Atlanta, USA and Oregon Health Sciences University, Portland, USA. Dr. Kandimalla worked to develop new animal models of schizophrenia that take into account the purported neurodevelopmental features of the disease including its clinical manifestation following the onset of puberty under the super vision of Dr. Remi Quirion at McGill University. At Emory University under the supervision of Dr. Huichen Wang, Dr. Kandimalla work focused on the mechanism of ionizing radiation (from high energy particles during space mission (NASA)-induced DNA double strand break repair in the central nervous system. Dr. Kandimalla found that radiation increased the neuronal progenitor cell death and reduced neuronal plasticity. Dr. Kandimalla work demonstrated inhibition of GSK3β in protecting neural cells from DNA damage and oxidative stress induced by x-ray, proton and high energy charge particles radiation. In addition, Dr. Kandimalla investigated the effect of amyloid beta on radiation induced DNA damage response in neuronal cells. Dr. Kandimalla got extensive training on the DNA damage response, neuronal stem cell, and neuronal plasticity. Along with this main project Dr. Kandimalla also worked on several of types of DNA repair mechanisms (by using engineered plasmids) in breast cancer and brain tumor. Dr. Kandimalla has shown lot of interest on latest advances in neuroscience like optogenetics, Knock-in / Knock-out Mouse via Cas9-CRISPR technology, Axonal guidance mechanisms, neuronal morphology by an advanced immunochemical technique, and cellular mechanisms of cognition by electrophysiology. Dr. Kandimalla writing skills are highly commendable and have very good teaching skills (Co-Mentored EMORY SURE PROGRAM Student). Dr. Kandimalla involved in Dr. Hemachandra Reddy (2) NIH R01 grants – Dynamin-related Protein 1 and Mitochondrial Fragmentation in Alzheimer’s disease (AG042178) and Voltage-dependent Anion Channel Protein 1 and Neurodegeneration in Alzheimer’s disease (AG047812). Currently Dr. Kandimalla primary focus is on maintaining mouse colonies, including heterozygote knockouts of dynamin-related protein 1 and voltage-dependent anion channel 1, and transgenic lines of amyloid precursor protein and mutant tau mice. He created double mutant lines (Tau X Drp1+/-; APP X Drp1+/-; Tau X VADC+/- and APP X VDAC1+/-) and involved with characterizing for mitochondrial structure/function, synaptic activity and amyloid beta and tau pathologies. Dr. Kandimalla uses multiple techniques and approaches, including molecular biology and cell biology, cell culture and light/fluorescence/confocal microscopies. Dr. Kandimalla is author and/or co-author for more than 35 peer-reviewed articles. Dr. Kandimalla is also reviewer and editor for various neuroscience and biochemistry journals.
Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, Kaifeng, ChinaCOVID-19; Emerging Viruses; Monkeypox Virus; Clinical Infectious Diseases; Infectious Disease Epidemiology; Viral Infection; Cancer; Tumor Suppression Gene; Hydrogen Sulfide and Nanomedicine and Medical Microbiology
PostDoc, PhD Cell Biology at Henan University.
Research Center for Clinical Medicine, First Affiliated Hospital of Kunming Medical University, Kunming Medical University, Kunming, Yunnan, ChinaImmunological Mechanisms; Infectious Diseases; Immunotherapy Strategies for Diseases
Professor and Principle Investigator at Kunming Medical University
Cancer Biology Laboratory & DBT-AIST International CENter for Translational and Environmental Research (DAICENTER), Department of Biosciences and Bioengineering, Indian Institute of Technology (IIT) Guwahati, Guwahati, IndiaInflammatory Pathways and Chronic Diseases; Cancer Biology and Therapeutics
Professor, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati.
Major research work accomplished at IITG so far:
Institute of Transfusion Medicine and Immunology, Mannheim Institute for Innate Immunoscience (MI3), Medical Faculty Mannheim, Heidelberg University, Heidelberg, GermanyInnate Immunity; Immunometabolism; Cancer Immunology; Diabetes; Regeneratvie Medicine
Professor of Cell and Moleculr Biology, University of Heidelberg.
Prof. Kzhyshkowska currently works as a Professor, and the Head of the Department for Innate Immunity and Tolerance at the University of Heidelberg. She mainly focuses on cell biology, inflammation, scavenger receptor, molecular biology, and immunology. Her cell biology research is multidisciplinary, incorporating perspectives in cell surface receptor and nucleotide excision repair, DNA repair protein XRCC4, and homology-directed repair. She studied inflammation and cytokines that intersect with proinflammatory cytokines, implant failure, and implant interaction with host and ex vivo. The various areas that she examines in her molecular biology study include receptor, DNA repair, and interleukin 4. Much of her study explores immunology's relationship to macrophages. Her macrophage research is multidisciplinary, incorporating elements of adipose tissue macrophages and pathogenesis and pathology.
Systems and Network Medicine Lab, Faculty of Medicine and Health Technology (MET), Tampere University, FinlandSystems Medicine; Systems Biology; Network Biology; Mechanistic Model; Machine Learning; Cancer Biomarker and Therapy; Non-coding RNA
1. Sperimental and Clinical Medicine Department, Faculty of Medicine, University of Foggia, Foggia, Italy
2. Biomedical Center, Applied Physics Laboratory, Via Napoli 20 c/o OO.RR. Foggia, ItalyEnvironmental Toxicology; Ecotoxicology; Cancer Diagnostics, Raman MicroSpectroscopy, FTIR Spectroscopy, Immunofluorescence Microscopy, Material Characterization; Atomic Force Microscopy
Associate Professor in Applied Physics at university of Foggia, Foggia, Italy.
Dr. Maria Lasalvia is currently working as Official Biologist at University of Foggia, Applied Physics Laboratory. She obtained her Ph.D. in Biology from same University. Her main area of interest related to Pharmacology and Toxicology, Biomedical Sciences, Molecular Sciences, Physical Science Engineering, and Environmental Sciences. Her area of expertise includes Biological Research, RAMAN Micro Spectroscopy, Atomic Force Microscopy, Pesticides, Occupational Safety and Health, Cells Culture, Cells Viability Test, FTIR (Fourier Transform Infrared Spectroscopy), Fluorescence Microscopy, Live Cells Analysis, Blood Analysis, Analytical Techniques for Chemical Analysis, and Protein Biochemistry Techniques. She has published 74 research articles in journals and conferences as author/co-author.
Department of traslational medicine, University of Ferrara, Ferrara, ItalyOral Medicine and Biology; Pediatric Dentistry; Molecular Biology of the Oral Cavity; Microbiology of the Oral Cavity in Leukemic Pediatric Patients: PCRealtime Study; Neurophysiological Study of Peripheral Neuropathies of the Oral Cavity; MAPkinases in the Precancerous Lesions of Oral Mucous Membranes
Professor (Associate) at University of Ferrara.
Institute of Biomedical Technologies, National Research Council (CNR), Pisa, ItalymiRNAs; Non-coding RNAs; NSCLC; Murine Models; Therapeutic Targeting; Drug Resistance Mechanisms; Cancer Stem Cells; Single Cell Transcriptomics; Transcription Factors; KRAS; EGFR; BMI1
First Resercher at Italian National Research Council.
Dr. Elena Levantini currently works at the Boston BIDMC Hospital. Elena does research in Cancer Research, Cell Biology and Molecular Biology. Their most recent publication is 'Abstract 5864: Novel anti-BMI-1 therapy in non-small cell lung cancer'.
Center For Advanced Spinal Surgery, Tucson, AZ, United StatesOrthopedic Surgeons Diagnose; Treat Ailments affecting Muscles; Bones and Joints; Treating Sports Injuries; Degenerative Diseases; Tumors; Infections; Birth Defects
Dr. Kaiuwe Lewandrowski is an orthopedist in Tucson, Arizona and is affiliated with Carondelet St. Mary's Hospital, El Dorado Surgery Center-Tucson and Surgical Institute of Tucson. He received his medical degree from Humboldt University of Berlin- Charite Faculty of Medicine and has been in practice for more than 20 years. Dr. Kaiuwe Lewandrowski has expertise in treating spinal fusion, spinal stenosis and spondylosis, among other conditions - see all areas of expertise. Dr. Kaiuwe Lewandrowski accepts Medicare, Aetna, Humana, Cigna, Blue Cross, United Healthcare - see other insurance plans accepted.
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaMulti-omics; Immune Microenvironment; Metabolism Biotherapeutic Targets; Clinical Prediction Model; Disease; Artificial Intelligence Technology
Dr. Li practices in Zhengzhou, China. Their top areas of expertise are Ectopic Pregnancy and Lewy Body Dementia (LBD).
Their clinical research consists of co-authoring 17 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Winship Cancer Institute, Emory University, Atlanta, United StatesCell Culture; PCR; Western Blot Analysis; Gel Electrophoresis; Cancer Biology; Electrophoresis; DNA Extraction; Cloning; DNA; SDS-PAGE
M.D, Researcher at Emory University.
EXPERIENCES
Clinical Research Coordinator IV, Sep. 2024 – Present
Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA
Clinical Research Coordinator III, Dec. 2022 – Sep. 2024
Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA
Clinical Research Coordinator III, Feb. 2018 – Dec. 2022
Winship Cancer Institute, Emory University, Atlanta, GA
Clinical Research Associate, Apr. 2017 - Feb. 2018
Morley Research Consortium, Atlanta, GA
Stem Cell and Biotherapy Engineering Research Center of Henan Province, Xinxiang Medical University, Xinxiang, ChinaStem Cells; Neural System Diseases; blood; Gene-modified
Guest Researcher at the Department of Anatomy, Faculty of Medicine, Friedrich Schiller University Jena, Germany; Part-time Researcher at Universiti Sains Malaysia (USM).
Member of the European Neuroscience Association, Director of the Henan Society for Cell Biology, and Chair of the Stem Cell Specialty Committee.
Department of Neurochemistry, Inge Grundke-Iqbal Research Floor, New York State Institute for Basic Research in Developmental Disabilities, New York, United StatesAlzheimer’s Disease; Down Syndrome; Neurodegeneration; Tau; Alternative Splicing; Phosphorylation; Kinase; Phosphatase; TDP-43; Truncation; O-GlcNAcylation; Propagation of Tau Pathology
Ph.D.， New York State Institute for Basic Research in Developmental Disabilities。
Department of Cell and Developmental Biology, John Innes Centre, Norwich Research Park, Norwich NR4 7UH, United KingdomBioinformatics; Big Data Mining; Epigenomics
Professor at Henan University. Henan University.
Young Talent of the Zhongyuan Talent Plan (Talent Introduction Track), Henan Province;
Fellow of the Royal Society of Biology, UK;
Visiting Expert of the CAST Overseas Talents Program (Hai Zhi Plan);
Fourth-Level Distinguished Professor at the Distinguished Talent Zone, Henan University.
Department of Neurosurgery, University of Florida, Gainesville, United StatesNeurosurgery; Neuroscience; Subarachnoid hemorrhage; Traumatic brain injury
Brandon Lucke-Wold was born and raised in Colorado Springs, CO. He graduated magna cum laude with a BS in Neuroscience and distinction in honors from Baylor University. He completed his MD/PhD, Master’s in Clinical and Translational Research, and the Global Health Track at West Virginia University School of Medicine. His research focus was on traumatic brain injury, neurosurgical simulation, and stroke. At West Virginia University, he also served as a health coach for the Diabetes Prevention and Management program in Morgantown and Charleston, WV, which significantly improved health outcomes for participants. In addition to his research and public health projects, he is a co-founder of the biotechnology company SwiftScience, the pharmaceutical company ProPhos Neuroscience, and was a science advocate on Capitol Hill through the Washington Fellow’s program.
He has also served as president of the WVU chapters for the American Association of Pharmaceutical Scientists, Neurosurgery Interest group, and Erlenmeyer Initiative Entrepreneur group. In addition, he has served as vice president for the graduate student neuroscience interest group, Nu Rho Psi Honor Society, and medical students for global health. He was an active member of the Gold Humanism Honor Society and Alpha Omega Alpha Honor Society. He is currently Vice President of the UF House Staff Council, Chair of the Quality Improvement Committee, on the Board of Directors for the Alachua County Medical Society, and active member of Institutional Review Committee and Accreditation Requirements Review Committee. He is married to Noelle Lucke-Wold and has two children. As a family, they enjoy running with their dogs, rock climbing, and traveling. In his spare time, Brandon frequently runs half marathons and 10ks together with is wife. Brandon also enjoys reading, playing piano, discussing philosophy, and playing chess. He is currently a Pgy6 neurosurgery resident at University of Florida with pursuing endovascular enfolded training and was awarded the Dempsey Cerebrovascular Research Fellowship, SNS Fellowship, Van Wagenen Fellowship, R25 Grant, and SNIS Fellowship.
Department of Mathematics and Statistics, University of York, Toronto, CanadaBig data mining in biomedicine; Vaccination; Global health; Biostatistics; Data science
Nicola Luigi Bragazzi got his MD in general medicine and surgery from Genoa University (Genoa, Italy) in 2011, his PhD in biophysics from Marburg University (Marburg, Germany) in 2014 and his specialization in Public Health from Genoa University (Genoa, Italy) in 2017. He is a member of the Cochrane Association (Cochrane Reviewer) for the Cochrane Epilepsy Group. He has been awarded Young Knight of the Italian Republic by the President Carlo Azeglio Ciampi in 2005. Recently, in 2019, he has been nominated as one of the top five biomedical researchers worldwide aged less than 40 years in terms of number of publications, articles in Q1 biomedical journals, total impact factor and h-index. He is currently working on infectious disease and vaccination modelling and big data mining in biomedicine at York University.
School of Basic Medical Sciences, Henan University, Kaifeng, ChinaPhysiology; Receptors; Quantum Dots; Receptor; Opioids; ZnO; G-Protein-Coupled Receptors; Neuropharmacology; Neuropeptides; Pain; Depression
Ph.D., Professor (Associate) at Henan University.
Director of the Institute of Molecular Medicine at Henan University; Recipient of the Henan Province Excellent Young Scientists Fund; Selected for the Henan Province Young Talent Support Program; Young Key Faculty Member of Henan Higher Education Institutions; Kaifeng Science and Technology Innovation Talent; Served as a peer reviewer for the National Natural Science Foundation of China (NSFC),
Review Editor for Frontiers in Genetics, and reviewer for more than 10 academic journals, including Theranostics and Frontiers in Oncology. Also serving as a Young Committee Member of the Chinese Society of Microcirculation, Division of Translational Medicine, Director of the Henan Society for Health Science, and Standing Committee Member of the Henan Society for Infection and Molecular Immunology.
Department of Pharmaceutical Sciences, College of Pharmacy, WSH, University of Nebraska Medical Center, Omaha, United StatesNanomedicine; Biophysics; DNA Replication and Recombination; Protein-DNA Interaction; Chromatin Structure and Dynamics; Alzheimer's Disease; Parkinson's Disease; Amyloid Protein Aggregation; Protein Misfolding; Alpha-Synuclein; Beta Amyloid; Protein–Protein Interaction; Computational Modeling; Nanoimaging; Single-Molecule Biophysics; Force Spectroscopy; Atomic Force Microscopy; AFM
Professor, UNMC Department of Pharmaceutical Sciences.
Dr. Lyubchenko received his doctoral training in Molecular Biophysics at the Moscow Institute of Physics and Technology, a top-ranked School in the former Soviet Union. He developed an active research program in the physical chemistry of nucleic acids at the Institute of Molecular Genetics in Moscow. He received the degree of Doctor of Science (the top scientific degree in the former USSR) for this research. He is currently a professor at Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE. Research in the Lyubchenko lab focuses on understanding fundamental mechanisms underlying health and disease, which are key to developing new and more effective diagnostics and medications. The research is categorized into four broad areas, with interplay and overlap among them (1) Structural genomics in relation to cancer and other diseases, (2) Molecular mechanisms Alzheimer’s, Parkinson’s and other protein aggregation diseases, (3) Protein-DNA interactions for novel approaches for HIV restriction.
Senior Bioinformatics Scientist in the Department of Bioinformatics at MedGenome Labs Ltd. Bangalore, IndiaBioinformatics; Genetics; Genomics; Next-Generation Sequencing; Proteomics; Mass Spectrometry; Cancers; Infectious Biology; Integrated Analysis of -omics Data; Machine Learning and Biostatistics
Ph.D., Senior Bioinformatics Scientist at Medgenome Labs.
Dr. Madugundu, Ph.D., currently working as a Senior Bioinformatics Scientist at MedGenome. I have carried out my graduate and postdoc work focussing on the bioinformatics analysis of next-generation sequencing based genomics and mass spectrometry based proteomics at the Johns Hopkins, Baltimore, MD and the Mayo Clinic, Rochester, MN in addition to my affiliation to the Institute of Bioinformatics in India. I have more than a decade of experience in developing computational biology solutions to analyze and interpret genomics and proteomics raw data. I have published nearly 70 papers across a spectrum of peer-reviewed journals including in Nature, The Lancet, Genome Biology, Genome Research, Molecular and Cell Proteomics, The Journal of Clinical Investigation, etc.
Nathan S. Kline Institute for Psychiatric Researchdisabled, Orangeburg, United StatesTranslational Medicine; Neurodegenerative Disorders; Autophagy and lysosome pH
Postdoctoral Researcher at Nathan S. Kline Institute for Psychiatric Research, Orangeburg, United States
WiscNano, School of Pharmacy,University of Wisconsin-Madison, Madison, United StatesNanoBiomaterials; Advanced Drug/Gene Delivery Systems; Cancer Immunotherapy; Bone/tissue engineering
Dr. Mamidi holds the position of Scientist at WiscNano, School of Pharmacy, University of Wisconsin-Madison (UW-Madison), USA. His primary research focus lies in the innovative development of nano-formulations for co-drug-gene delivery and cancer immunotherapy. Prior to his affiliation with UW-Madison, Dr. Mamidi served as an Assistant Professor in the Department of Chemistry and Nanotechnology at Tecnologico de Monterrey (TEC). During his tenure at TEC, he spearheaded multidisciplinary research endeavors that integrated novel chemistries with nanoscale technologies to create advanced biomaterials for diverse biomedical applications. Dr. Mamidi’s team has achieved significant breakthroughs in the design of customizable biomaterials, tailored for applications such as drug delivery, orthopedic implants, tissue engineering, biomedical devices, and environmental remediation. His contributions to the field are well-documented, with over 45 research articles published in prestigious journals. Notably, his work has garnered more than 1000 citations, demonstrating his influential presence in the scientific community.
Acknowledging his outstanding achievements, Dr. Mamidi has received various accolades, including the prestigious 2015 Eli Lilly Award, the 2018 National Research System (SNI) award, and the 2021 SNI award from the National Council for Science and Technology. In recognition of his exemplary contributions, Dr. Mamidi was honored as an outstanding research professor at the School of Engineering and Science, TEC in 2020. Furthermore, Dr. Mamidi actively contributes to the dissemination of knowledge within his domain as an editorial member for several reputable nanomedicine and nanotechnology journals. His dedication to interdisciplinary research and commitment to advancing biomaterials for biomedical applications further underscore his standing as a key researcher in the field.
Centre for Genomics and Oncological Research, Pfizer-University of Granada-Andalusian Regional Government, Granada, SpainBioinformatics; Bioinformatics and Computational Biology; Next Generation Sequencing; R Programming; Genomics; Gene Regulation; Sequencing RNA; DNA Sequencing; DNA
PhD, Postdoctoral researcher at Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research.
Genomic Medicine Research Group, University of Santiago de Compostela, Santiago de Compostela, SpainDrug Discovery; Immunometabolism; Targeted Therapy
Postdoctoral research associate.
Dr. Medina is a Senior Investigator in Genomic Medicine group at Center for Research in Molecular Medicine and Chronic Diseases (CiMUS) at the University of Santiago de Compostela. Prior to that, I was a postdoctoral Fellowship at The Scripps Research Institute in chemical physiology.
We are interested in discovering novel molecules and targets with potential therapeutic interest in oncology and metabolic disease. I participated in Open Innovation joint efforts and consortiums devoted to identify new drugs for unmet clinical needs. We have developed drug discovery platforms focused on novel target-based and phenotypic assays, high-content imaging, biological tools, DNA-encoded libraries screening, and immunopharmacology. In summary, we study relevant mechanisms associated to disease and immune response to translate them into innovative therapies useful to patients.
Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, ItalyAmyloidosis; Renal Biopsy; Autoinflammatory Diseases; Pathology, Serum; Multiple Myeloma; Rheumatoid Arthritis; Chemotherapy; Oncology; Hematology
Department of Molecular Medicine, Sapienza University of Rome, Rome, ItalyPrimary Immunodeficiencies; Secondary Immunodeficiencies; Quality of Life; Lung Diseases; Non-Infectious Complications of Immunodeficiencies
1. Hubei Key Laboratory of Embryonic Stem Cell Research, Faculty of Basic Medical Sciences, Hubei University of Medicine, Shiyan, China;
2. Department of Histology and Embryology, Faculty of Basic Medical Sciences, Hubei University of Medicine, Shiyan, ChinaNeuroinflammation; Neuromodulation; Pain; Depression
Department of Internal Medicine, University of Genova, Genova, ItalyPharmacogenomics; Immunology; Vaccines; Biologics; HIV; Allergies; Atherosclerosis; Autoimmunity; Immune-mediated diseases; Immunodeficiency; Neuroendocrine-immunology
Giuseppe Murdaca has received his PhD in Science and Space Engineering at the University of Genova (Italy) during the period of 2000-2003. Currently, he is working as Assistant professor in Internal Medicine University of Genova (Italy).
His research has included Immunodeficiency Autoimmunity Neuro-endocrino-immunology Pharmacogenomics.
Based on this research and fellowship training he has received several awards and honors, such as:
Prize for young researchers of the study, assigned by the GILS, with the following motivation: "Standardization of a method to assess impairment by skinfold thickness skin", delivered on the occasion of the "Day VII Italian to fight Scleroderma" (Milan, 17/3 / 2001).
Award for one of the three best oral presentations at the Ninth Congress of the Inter-SIMI Piemonte and Valle D'Aosta, Liguria (Genoa, 06.17.2004): Murdaca G., Fenoglio D., M. Setti, Brenci S., Villa R., Pontali E., A. Kunkl, Indiveri F., Puppo F. "Generation of CD4 + lines specific for Pneumocystis carinii and Candida albicans obtained from HIV + patients. Meaning of the coexpression of IFN-? and IL-4 ".
Department of Biological Sciences and Biotechnology, University Kebangsaan Malaysia, Bangi, MalaysiaPCR; Cell Culture; Gel Electrophoresis; DNA; SDS-PAGE; Antibacterial Activity; RNA Isolation; Cancer; Fisheries; Basic Bioinformatics
Post doctoral researcher, PostDoc Position at National University of Malaysia.
Dr. Najm is a postdoctoral researcher at Universiti Kebangsaan Malaysia (UKM), received a PhD in Microbiology, a Master in Conservation Biology from UKM and a Bachelor of Medical Laboratory Technologies from AL-Mamoon University, Baghdad, Iraq. He has over five years of academic experience. His research interests lie in biology, cell biology, molecular biology, biochemistry, and fisheries. He contributed to some academic papers and projects in line with his research interests.
Leading scientist of the molecular nanomedicine lab, Department of translational medicine, Sirius University of Science and Technology, Krasnodar,RussiaNanomedicine; Immune Metabolism; Cancer; Sepsis; Pulmonary Biology
Doctor of Philosophy, Leading Scientist at Sirius University of Science and Technology.
Dr. Parodi is a biological/medical researcher with significant experience in drug formulation, PK, nanomedicine, drug delivery, and immune metabolism. His research activity is devoted to designing, performing, analyzing, and interpreting data derived from extensive biological testing, material characterization, toxicology, and drug pharmacokinetics.
Department of Surgery (Transplant surgery), Medical University of South Carolina , United StatesAutoimmune; Complement; Inhibitor; Trauma; Spinal Cord Injury; Stroke; Ischemia/Reperfusion Injury; Cardiocytes; Transplant Immunity and Tolerance
Assistent professor at Medical University of South Carolina.
Key Laboratory of Protein and Peptide Pharmaceuticals, CAS-University of Tokyo Joint Laboratory of Structural Virology and Immunology, Institute of Biophysics, Chinese Academy of Sciences, Beijing, ChinaProteins 100; Cancer Associated Fibroblast; Fibroblast Activation Protein Alpha; Tumor Microenvironment
Professor at Zhengzhou University, Researcher at the Institute of Biophysics, Chinese Academy of Sciences, National Science Fund for Distinguished Young Scholars awardee, Chief Scientist of the National "973" Program, and Executive Committee Member of the Tumor Immunology and Biotherapy Branch of the Chinese Society for Immunology. Currently serves as the Director of the Immunology Center at the Medical Sciences Academy of Zhengzhou University and concurrently as the Director of the Medical Research Center at the First Affiliated Hospital of Zhengzhou University.
Academy of Medical Sciences, School of Medicine, Zhengzhou University, Zhengzhou, ChinaProstate Cancer; Tumor Biology; Epigenetics; Chimeric RNAs in Cancer
Distinguished Professor and Academic Backbone of Zhengzhou University, Doctoral Supervisor. He received his Bachelor's degree in 2003 and earned his Ph.D. in Biochemistry and Molecular Biology from Huazhong Agricultural University in 2010. He conducted postdoctoral research at Northwestern University, USA, from 2010 to 2012. From 2012 to 2016, he served as a Research Associate at the University of Virginia, USA, and was promoted to Research Scientist from 2016 to 2020. His research has been supported by grants from the National Natural Science Foundation of China (NSFC), including the General Program and the NSFC-Henan Joint Fund Project.
Department of Experimental and Clinical Medicine, Section of Anatomy and Histology, University of Florence, Florence, ItalyAnatomy; Histology; Morphological and Functional Aspects of Stromal Cells and Endothelial Cells; Angiogenesis; Tissue Fibrosis; Systemic Sclerosis; Scleroderma
PhD, Research Associate at University of Florence.
Department of Medical Sciences, University of Ferrara, Ferrara, ItalyCancer; MCC; MCPyV; Large T Antigen; Antibody; Antigen; ELISA; Infertility; SARS-CoV-2; Prevalence
PhD, Researcher, Principal investigator at Azienda Ospedaliera Universitaria San Martino di Genova.
Dr. Rotondo's main research interests are cell and tumor biology, epigenetics, virology, viral oncology. Looking for collaborations!
1. Department of Electrical and Computer Engineering, Georgia Tech Shenzhen Institute (GTSI), Tianjin University，Shenzhen, China
2.Department of Electrical and Computer Engineering, Georgia Institute of Technology, Atlanta, United StatesPCR; Cell Culture; Gel Electrophoresis; DNA Extraction; DNA Gel Electrophoresis; Electrophoresis; DNA; Cloning; Protein Purification; Western Blot Analysis
Ph.D. , Assistant Professor at Georgia Institute of Technology.
Dr. Aly Saad Aly’s research interests focused on microfluidics-based LOC for biomedical applications. Furthermore, his research interests include nanotechnology-based electrochemical and biosensors. Moreover, nanoparticles-based smart drug delivery systems for viral and cancer therapy are one of his recent research interests. Additionally, research work based on smart biomaterials such as responsive polymer sand hydrogel is an active research interest for Dr. Aly Saad Aly.
Institute of Neurophysiopathology (INP), Aix-Marseille University, Marseille, FranceAntimicrobial Peptides; Antibacterial; Antibiotics; Structure-Activity Relationships; Bacteriocins; Drug Design; Peptide Engineering; Antivirals; Infectious Disorders
PhD & HDR, French National Centre for Scientific Research.
Dr. Sabatier is a Director of Research at CNRS affiliated to the Institute of NeuroPhysiopathology, UMR 7051, Marseille (France). He is acting as: Editor-in-Chief of "Journal of Current Toxicology and Venomics"; Editor-in-Chief of "Coronaviruses"; Topic Editor-in-Chief of "Antibiotics" (IF: 4.3); Associate Editor of "Frontiers in Pharmacology" (IF:4.4); Associate Editor of "Journal of Advanced Research" (IF: 11.4); Editorial Board Member of 75 journals. Reviewer for journals with IF up to 35.
Gomal Centre of Biochemistry and Biotechnology, Gomal University Dera Ismail Khan, PakistanRtole of Bioinformatics in Cancers; Biomarkers in Early Detection of Cancers; Potential Subtype-Specific Therapeutic Targets
Dr. Saddozai is fromSchool of Basic Medical Sciences, Henan University College of Medicine, Kaifeng, Henan, China and has done research on title "PCNP is a Novel Regulator of Neuroblastomas Cancer" and many more.
Dept. of Applied Sciences, Indian Institute of Information Technology, Allahabad, IndiaBiochemistry; Nanobiotechnology; Bioinformatics
Department of Advanced Medical and Surgical Sciences, Università degli Studi della Campania Luigi Vanvitelli, Naples, ItalyHeart Failure; Atrial Fibrillation; Echocardiography; Electrocardiography; Clinical Cardiology; Chronic Heart Failure; Cardiac Function; Myocardial Infarction; Hypertension; Cardiovascular Medicine
Dr. Sardu is an Associate Professor at the Department of Advanced Medical and Surgical Sciences, University of Campania “Luigi Vanvitelli”, Naples, Italy. He authored/co-authored 155 publications and 4739 citations with an h-index of 41 (Scopus, December 2023). His research interests focus on heart failure, atrial fibrillation, echocardiography, electrocardiography, clinical cardiology, chronic heart failure, cardiac function, myocardial infarction, hypertension, and cardiovascular medicine.
Department of Pharmacology, Yong Loo Lin School of Medicine, Queenstown, SingaporeCancer; Inflammation; Transcription factors; Vitamin; Apoptosis
Associate Professor at the Yong Loo Lin School of Medicine, Queenstown, Singapore.
Dr. Sethi is the editorial board member of 11 different international journals.
AVAILABILITY
-
Collaborative projects
-
Industry Projects
-
Masters Research or PhD student supervision
-
Join a web conference as a panellist or speaker
-
Mentoring (long-term)
-
Media enquiries
-
Mentoring (short-term)
1. Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Jamia Nagar, New Delhi, India
2. Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman, United Arab EmiratesCancer Therapeutic; Kinase Inhibitors; Natural Compounds; Protein Biochemistry; Drug Design and Discovery
Dr. Mohammad Anas Shamsi is a Research Assistant Professor at the Center for Medical and Bio-Allied Health Sciences Research. His research area is Structure-based Drug Design and Discovery. He is working in the most exciting areas of medicinal chemistry with a special focus on structure-based drug design and discovery, targeting the discovery of new drugs for the treatment of Cancer and Alzheimer's and related neurodegenerative diseases.
School of Pharmacy, Henan University, Kaifeng, ChinaNanoparticulate Drug Delivery Systems; Gene and Immunotherapy of Cancer; Injectable Hydrogel for Biomedical Applications
Ph.D., Professor, Henan University, Kaifeng, China
Appointed Deputy Dean of the School of Pharmacy in September 2022.
Department of Pharmacy (DIFARMA), University of Salerno, Fisciano, ItalyCancer; Carcinogenesis; Lung Cancer; Drug Resistance; Immunotherapy; Inflammation
Associate Professor in Pharmacology and Pharmacotherapy, University of Salerno, Italy.
2024 to present: Member of the IUPHAR Cancer Pharmacology Committee
2010 to present: Member of the Italian Society of Pharmacology (SIF)
Member of the SIF Oncology Pharmacology Group, directed by Prof. Mini
Co-coordinator with Prof. Giorgio Minotti of the Clinical Oncology Pharmacology subgroup
Co-coordinator with Prof. Giuseppe Nocentini of the Oncology Immunopharmacology subgroup
Member of the SIF Environmental Toxicology subgroup: coordinated by Prof. Raffaella Sorrentino
2022 to present. Member and Ambassador of the European Association of Cancer (EACR) (EACR33315 member)
2015 to present: Member of the Universal Scientific Education and Research Network, USERN, "Cancer Immunology project" section: https://usern.tums.ac.ir/Group/Info/CIP
2013 to present: Member of the European Respiratory Society (ERS)
2011 to present: Member of the Italian Society of Immunology, Clinical Immunology and Allergology (SIICA)
Laboratory of Tissue Engineering, Department of Clinical and Experimental Sciences, School of Medicine, University of Brescia, Brescia, Italy3D in Vitro Models (liver, lung, articular cartilage, bone, multiple myeloma, breast cancer etc); in Vitro Toxicology; in Vitro Investigations of Air and Water Pollution; Tissue Engineering; Stem Cell Biology; Cell Biology; Biomedical Engineering; Cells; Cancer Biology; Heavy Metals; Regenerative Medicine
PHDs, post PhD - toxicologist at University of Brescia.
Dr. Steimberg currently works at the Department of Clinical and Experimental Sciences, Università degli Studi di Brescia. Nathalie does research in Cell Biology, Human Biology and Pathology. Their current project is 'Establishment of innovative ex-vivo/in-vitro 3D culture systems for physiopathology and pharmaco-toxicology studies.'. Main organ/tissues studied are healthy or pathological articular cartilage, Intervertebral disc, and concerning our expertise in tumour field we developed 3D models for multiple myeloma and works are in progress to develop breast cancer models.
Department of Experimental Medicine, Sapienza University, Rome, ItalyCell Culture; Cell Signaling; Cancer Biology; PCR; Molecular Biology; Gene Regulation; Epigenetics; Apoptosis; Western Blot Analysis
Doctorate, Associate Professor, Sapienza University of Rome, Rome, Italy.
EDUCATION AND CAREER
2015-present Associate Professor, General Pathology, MED/04
2010-2015 Assistant professor, General Pathology, MED/04
2007-2010 Assistant professor, Department of Cellular and Molecular Pathology, IRCCS San Raffaele Pisana, Rome.
2004-2007 Post-Doctoral Fellow, Department of Experimental Medicine, Sapienza University.
2000-2004 Assistant professor, Thomas Jefferson, Philadelphia, PA, USA
1997-2000 Research Technician, Thomas Jefferson, Philadelphia, PA, USA
1999-2003 PhD in Human Pathology, Department of Experimental Medicine, Sapienza University.
1994 Degree in Biology, Tor Vergata University, Rome.
MOST RELEVANT RESEARCH LINES
1) Hypoxia and inflammation in tumor progression
2) Sirtuins in cellular physiology and pathology
3) Mechanoreceptors and sirtuins in space biomedicine
COLLABORATIONS
Prof. Pankaj K Singh, University of Nebraska, Omaha, NB, USA
Prof. Gregg L Semenza, Johns Hopkins University, Baltimora, MD, USA
Prof. Matteo A Russo, MEBIC, San Raffaele Pisana, Roma
Dr Federica Limana, Università San Raffeale, Roma.
Prof. Antonello Mai, Università Sapienza
Prof. Mariano Bizzarri, Università Sapienza
Prof. Marco Cordani, Complutense University, 28040 Madrid, Spain.
Department of Applied Biology and Chemical Technology and PolyU Laboratory for Probiotics and Prebiotics in Human Health, The Hong Kong Polytechnic University, Hong Kong SAR, ChinaCancer Therapy; Probiotics; Microbiota; Renal Diseases; Cellular Immunotherapy; Drug Development; Inflammatory Bowel Disease
Assoicate Editor (Frontiers in Pharmacology).
of cancer and inflammatory diseases; and (3) BK polyomavirus in renal transplantation and outcomes.
Department of Diagnostic Senology, Caserta Local Health Authority, Caserta, ItalyBreast Cancer Imaging; Radiology; Oncology; Epidemiology; Screening
Daniele Ugo Tari, MD, is a radiologist and senologist. His work broadly focuses on breast disease imaging, screening, and prevention. His professional experiences include the following: Director of the Department of Breast Imaging, District 12, Caserta LHA. Medical Degree at the University of Campania, "L. Vanvitelli", in 2009. Post-graduation in Radiology at the University of Naples, "Federico II", in 2015. Master in Management of Radiology Unit at SIRM, in 2021. Master in Healthcare Management at Pegaso University, in 2022. Director of the Department of Diagnostic Senology, District 12, Caserta LHA. Past residency training was at the AOU Ospedali Riuniti, Ancona, Italy. He was the Principal Investigator/Scientific Director for several studies and research projects at his department in the fields of breast imaging, breast disease, oncology, and public health, focusing on multimodalities and multidisciplinarity. He has published more than 80 national and international papers. He has attended as a speaker and moderator at several national and international congresses. He is an academic and guest editor, and ad hoc reviewer for several journals with high impact factors. Professional societies include the Italian College of Senologists and the Italian School of Senology, the Italian Society of Medical and Interventional Radiology, the European Society of Radiology, the European Society of Breast Imaging, and the Italian Group for Mammography Screening.
School of Pharmacy, University of Camerino, Camerino, ItalyNeuroscience; Cell Culture; Synthesis; Neurobiology; Neuropharmacology; Neurobiology and Brain Physiology; Neurophysiology; Neurodegeneration; Electrophysiology; Neurodegenerative Diseases
PharmD, PhD, ClinPharmD
Professor (Associate) at Università di Camerino
School of Medicine, The City University of New York, New York, United StatesChagas Disease; Host–pathogen Interactions; Immunity; Drug and Vaccine Discovery
School of Mathematics and Statistics, Henan University, Kaifeng, ChinaSystems Biology; Biostatistics; Omics Data Analysis
Henan Provincial Distinguished Professor, Professor and Doctoral Supervisor at Henan University. Recipient of the Henan Provincial Outstanding Youth Fund, Henan Provincial Excellent Young Scientists Fund, Henan Provincial University Innovation and Technology Talent Program, and Henan Provincial Key Young Faculty Program; Leader of the Kaifeng Municipal Innovative Science and Technology Team.
International Joint Research Laboratory for Recombinant Pharmaceutical Protein Expression System of Henan, Xinxiang Medical University, ChinaRecombinant Therapeutic Protein; Efficient Mammalian Cell Expression System; Gene Expression Regulation
Academy of Pharmacy, Xi'an Jiaotong-Liverpool University, Suzhou, ChinaImmunology; Molecular and Cellular Biology; Ophthalmology; Cancer Biology
Associate Professor, Senior Investigator, Taishan Scholarship Professor.
Dr. Wang received a Bachelor degree in Basic Medicine from Beijing Medical University (now Health Science Center of Peking University) and a PhD degree in pathophysiology from the Academy of Military Medical Sciences. After postdoc training in the Second Military Medical University and the University of Iowa (1996-2003), he started his career track in the University of Iowa, Shandong Academy of Medical Sciences, Soochow University, Xiamen University and Xi’an Jiaotong-Liverpool University sequentially. His research is to understand the mechanisms underlying the pathogenesis or treatment of diseases from the viewpoints of basic medical scientists. He published over 50 SCI-indexed papers in international journals plus over 50 papers in non-SCI-indexed journals covering immunology, microbiology, molecular biology, cellular biology, pharmacology (disciplines in sense of basic medicine), or hematology, oncology, ophthalmology, dermatology, autoimmune diseases (disciplines in clinical medicine). He also published two books as editors and issued nine inventory patents. He is member of several academic societies and on journal editorial boards. He pursues after novelty in science and enjoys research, especially on innovative theories. In the last ten years, one of his teams interests has been the functions of the gene MXRA7 and disclosed the clues to the significance of this gene in biomedical processes. His team has won several awards from Chinese agents or international academic societies.
Texas Tech Health Science Center, Lubbock and KinderGenome Medical Genetics, Dallas, TX, United StatesClinical Genetics; Relation of DNA Change to Genetic Diseases and Syndromes; Ehlers-Danlos syndrome and Connective Tissue Dysplasias
Dr. Golder Wilson, MD is a pediatrician in Lubbock, TX and has over 50 years of experience in the medical field.
Dr. Golder Wilson is a board-certified medical geneticist who became interested in EDS after 40 years of experience with syndromes involving intellectual disability, birth defects, and autism. After scholarship yielding 100 articles and 4 books on ~25,000 patients with the latter disorders, he has described the clinical and DNA findings of 2000-plus EDS patients in another 20 articles and a recent book available at The DNA of Ehlers-Danlos and Long COVID19 Syndromes: Healing Their Flexibility, Fatigue, and Fear: 9798313797625: Medicine & Health Science Books at Amazon.com.
1. Henan International Joint Laboratory for Nuclear Protein Regulation, Henan University, Kaifeng, Henan, China;
2. School of Stomatology, Henan University, Kaifeng, Henan, ChinaHydrogen Sulfide; Nucleoprotein; Metabolic Diseases
Full Professor of Physiology and Vice President of School of Stomatology at Henan University.
Dr. Dongdong Wu obtained his PhD from Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University, Shanghai, China. Currently he serves as Full Professor of Physiology and Vice President of School of Stomatology at Henan University and Executive Director of Henan International Joint Laboratory for Nuclear Protein Regulation (at Henan University). He has been elected to membership within a number of scientific committees across China, including Chinese Society of Immunology, Chinese Anti-Cancer Association, and Chinese Society for Microbiology. Dr. Dongdong Wu has authored more than 90 original research papers and review articles, upon research interests including hydrogen sulfide, nucleoprotein, and metabolic diseases.
State Key Laboratory of Tea Biology and Utilization, Anhui Agricultural University, Hefei, ChinaVascular Biology
Professor Zhongwen Xie is a Wangjiang Scholar and a Doctoral Supervisor in the School of Tea and Food Science and Technology at Anhui Agricultural University. He received a bachelor's degree from East China Normal University in 1986 and a PhD from the Chinese Academy of Sciences in 1999. Previously, he was a Post-Doctoral Fellow and Senior Scientist at the University of Kentucky in the United States. Currently, he serves as an executive member of the National Council of Food Nutrition and Health.
1. Department of Clinical Medicine, Henan Medical School, Zhengzhou, Henan, China;
2. Department of Immunology, Beijing University, Beijing, China;
3. Department of Immunology and pathology , Department of Ophthalmology and Visual sciences; Washington University in St. Louis, United StatesCells; MMP inhibitors and Neuroprotection; Immunotherapy
Professor. Graduated with a degree in Traditional Chinese Medicine Pharmaceutical Technology from Henan University of Chinese Medicine. Dr Yang has been engaged in teaching courses such as Principles and Equipment of Pharmaceutical Engineering and Chemistry of Traditional Chinese Medicine. Recipient of numerous honors, including "Teaching Master of Henan Provincial Higher Education Institutions," "Outstanding Mentor in the National Vocational Skills Competition," "Henan Craftsman Talent," "Advanced Mentor in the 'Master-Apprentice' Program of Henan Provincial Science, Education, and Health System," "Xinyang Municipal High-Level Talent (Category C)," "Xinyang Municipal Academic and Technical Leader," and "Xinyang Municipal Young Science and Technology Expert."
First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaHematological Malignant Disease Diagnosis and Treatment; Leukemia Immunotherapy; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cell Immuno-regulation
Dr. Yu is an academic researcher from Zhengzhou University.
1. School of Stomatology, Henan University, Kaifeng, China;
2. Kaifeng Key Laboratory of Periodontal Tissue Engineering, Kaifeng, ChinaOsteoporosis; Bone Remodeling; Stem Cells; Mitochondria Dysfunction; Bone Tissue Engineering; Periodontitis; Biomaterials
PhD, PostDoc Position at University of Rochester Medical Center.
School of Basic Medical Science, Henan University, Kaifeng, ChinaScreening and Pharmacological Research of Anti-tumor; Organic Small Molecular Compounds
Associate professor, and master supervisor, Henan University. Dr. Zhang is mainly engaged in the screening and pharmacological research of anti-tumor and anti-fat accumulation small molecule drugs.
First Affiliated Hospital of Zhengzhou University, Zhengzhou, ChinaInternal Medicine; Pulmonary Disease; Cardiology; Oncology; Infectious Disease; HIV; Clinical Trial and Health Management
Research Professor and Clinical Research Expert.
Dr. Zhang is a seasoned bilingual and bicultural leader in the clinical trial strategy and management space with many years of broad experiences across Internal Medicine, Pulmonary disease, Infectious disease, Cardiology, Oncology, and Healthcare management.
Department of Biochemistry and Molecular Genetics, The University of Alabama at Birmingham, Birmingham, Alabama, United StatesArginine Methylase; Leukemia; Megakaryocyte Differentiation and Blood
Associate Professor (Pathology and Lab Medicine).
Dr. Xinyang Zhao graduated from Fudan University in Shanghai, China with a B.S. degree in Microbiology in 1990. He then gained M.S. and Ph.D. degrees in Microbiology from SUNY at Buffalo in 1996. After a shot postdoctoral training at University of Toronto, he moved to Howard Hughes Medical School in Cold Spring Harbor Lab to study transcriptional regulation in Dr. Nouria Hernandez’s lab. In 2003, Dr. Zhao joined the research group of Dr. Stephen Nimer at Memorial Sloan Kettering Cancer Center in New York where he was promoted to senior research scientist position. Dr. Zhao studied protein arginine methyltransferases for their roles in epigenetic and transcriptional regulation using leukemia as disease model. He joined the Department of Biochemistry and Molecular Genetics and Stem Cell Institute at UAB in August, 2011.
epartment of Biochemistry and Molecular Biology, School of Basic Medicine, Huazhong University of Science and Technology, Wuhan, ChinaIdentify Novel Onco-kinase; Mechanism of Resistance of TKI in NSCLC; Mechanism of Skin Inflammation Diseases
Doctor of Medicine, Professor (Associate) at Huazhong University of Science and Technology.
1. Department of Biomedical and Clinical Science, University of Milan, Milan, Italy
2. Department of Pediatrics, Buzzi Children’s Hospital, Milano, ItalyPediatrics; Nutrition; Infectious Diseases; Health Care; Telemedicine; Translational Research; Rare Diseases; Non-Communicable Disaeses
Full Professor of Pediatrics at the School of Medicine, University of Milan, Italy
Head of the Department of Pediatrics, University of Milan, at the Children Hospital, Milan, Italy
Director of Pediatric Clinical Research Center
Vice Director of Biomedical and Clinical Science Department Università degli Studi di Milano
Servicio de Genética, Hospital Universitario Ramón y Cajal-IRYCIS, Madrid, SpainRare Diseases; Lysosomal Disorders; Hereditary Hearing Impairment; Hidradenitis Suppurativa; Genomic Screening Techniques; Murine Models of Disease
MSc PhD, Principal Investigator at Hospital Universitario Ramón y Cajal.
Board-Certified: American Board of Obstetrics and Gynecology
Fellow: American College of Obstetricians and Gynecologists
Residency: Obstetrics and Gynecology, Geisinger Medical Center, Danville, PA
MD: School of Medicine, University of San Luis Potosi, Mexico
BSc: Biology, University of Wisconsin, Madison, WI
Member: American College of Obstetricians and Gynecologists, Texas Medical Association, Cameron-Willacy County Medical Society
“I entered this field because it allows me to help patients get better with multiple treatments that work. I enjoy solving patients’ problems. I devote time talking to each patient in order to obtain a global view of the health issue or disease and how it affects them. I hope to give every patient high-quality, compassionate care because each one is special.”
Dr. del Castillo is proficient in the care of female diseases from adolescence through menopause. He is well-versed in gynecologic surgery, offering his patients both traditional and minimally invasive gynecologic surgery for such problems such as urinary loss and pelvic floor relaxation.
Section of Pathology, Department of Emergency and Organ Transplantation (DETO), University of Bari “Aldo Moro”, Bari, ItalyDermatopathology; Dermatology; Skin Diseases; Skin Tumors; Soft Tissue Pathology; Gynecopathology; Neuropathology
Pathologist, MD, PhD, IFCAP, Msc student.
Dr. Cazzato is an ICDP/UEMS Board Certified Dermatopathologist. He obtained a master’s degree in medicine from the University of Bari “Aldo Moro” in Italy and a PhD in clinical medicine, public health, and oncology at the same university. He is an International Fellow of the College of American Pathologists (IFCAP), and currently, he is an MSc Student of Molecular Pathology at the University of Cote d’Azur in France. Dr. Cazzato works as a pathologist at the University of Bari “Aldo Moro”, particularly in Dermatopathology, Soft Tissue pathology and Bone pathology and has international research collaborations with different institutions. Dr. Cazzato has submitted more than 40 abstracts to international conferences, published more than 200 papers in peer-reviewed journals and authored six book chapters.
Changzhou No.2 People’s Hospital, the Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, ChinaGynecological Endocrine Disease; Pelvic Floor Disease; Minimally Invasive Treatment of Gynecological Benign and Malignant Tumors; Transumbilical Single Hole Laparoscopy (TU-LESS); Transvaginal Natural Channel "scar free" Single Hole Laparoscopy (V-NOTES); Single Port Laparoscopic Surgery for Gynecological Benign and Malignant Yumors
Medical Doctor (Ph.D., Postdoctoral Fellow), Chief Physician, Professor, Doctoral Supervisor, and Postdoctoral Co-Supervisor.
Director of the Department of Obstetrics and Gynecology, Changzhou Clinical Medical College of Nanjing Medical University; Deputy Director and Ward Director of the Department of Gynecology, The Second Affiliated Hospital of Nanjing Medical University; Director of the Changzhou Gynecology Quality Control Center; Distinguished Expert in Obstetrics and Gynecology, Shangqiu Municipal Hospital, Henan University; and Flexible-Hire Talent and Clinical Director of Gynecology, The Third People's Hospital of Xining.
Stomatological Hospital, Southern Medical University, Guangzhou, Guangdong, ChinaCancer Metabolism; Tumor Microenvironment; Proteomics; Cancer Immunology
Dr. Li Cui serves as an Associate Professor at Southern Medical University. He earned his Doctor of Dental Surgery (DDS) degree from Sun Yat-Sen University and later completed his Ph.D. at the University of California, Los Angeles. Specializing in the study of the tumor microenvironment, Dr. Cui aims to bridge molecular and cellular mechanisms with clinical applications. He has an impressive publication record, having authored over 40 articles in prestigious, SCI-indexed journals such as ACS Nano, Analytical Chemistry, and Cancer Communications.
Keck School of Medicine of USC, Los Angeles, United StatesCancer Metastasis to the Brain; Blood-Brain Barriers; GABA Metabolism by Tumor Cells; Snake Venom Proteins, Toxins; Venom Proteins
Diganta is a Postdoctoral Researcher working on brain metastasis through neurobiology perspectives (microenvironment and brain barriers). Diganta received his PhD in snake venom protein chemistry from Tezpur University, Assam, India and has a sound experience in proteomics. He earned the technique of handling snakes and venom milking. Diganta enjoys a good guitar and photography binge but can also be found in the midst of wilderness.
Department of Medical Biology and Genetics, Facukty of Medicine, Gaziantep University, 27310, TurkeyCell Culture; PCR; Western Blot Analysis; Gel Electrophoresis; Electrophoresis; DNA; Cloning; SDS-PAGE; DNA Extraction; Cancer Biology
Associate Professor, Faculty of Medicine, Gaziantep University.
Dr. Sevgi Gezici has been working as a position of associate professor at Gaziantep University, Faculty of Medicine, Department of Medical Biology and Genetics. After receiving her bachelor degrees in Gaziantep University, Department of Biology between 2005-2009, she earned her M.Sc. and Ph.D. degrees in 2011 and 2017, respectively, Molecular Biology and Genetics at Gaziantep University, Turkey. During her Ph.D. studies, she got acceptance from Texas A&M University, Faculty of Life Sciences Research Center, and continued her Ph.D. studies in the United States of America for a short period in 2014. She has been a postdoctoral fellow at Kumamoto University, Department of Life Sciences, Japan. Additionally, during her M.Sc. and Ph.D. studies, she was awarded with TUBITAK scholarships. Dr. Gezici has authored or co-authored in more than 200 papers in peer-reviewed journals, and national/international meetings. She has attended many organizations as an attendee, a scientific committee and an organizing committee member in national/international congress, meetings and course. She has also given invited talks in international meetings and congress in the USA, Japan, Slovakia, Iran, Spain, Ukraine, Tunisia, Portugal, Egypt, Russia, India, Bulgaria, China, Italy, Spain, Thailand, and Turkey etc. She is a member of Editorial Advisory Boards of various journals in the field of Molecular Biology, Applied Pharmaceutical Sciences and Pharmacognosy. Co-Editor of Current Perspectives on Medicinal and Aromatic Plants (CUPMAP), Assistant Editor of Journal of Pharmaceutical Research (JPR) and Current Research in Pharmaceutical Sciences (CRPS). Scientific Secretary of International Mediterranean Symposium on Medicinal and Aromatic Plants (MESMAP) and International Symposium on Pharmaceutical and Biomedical Sciences (ISPBS). General Secretary of Global Federation of Medicinal and Aromatic Plants (GOFMAP), and Members of European Association for Cancer Research (EACR), Association of Medicinal and Aromatic Plants of Mediterranean (AMAPMED), Molecular Biology Association of Turkey and Honorary Faculty Members of ‘Novel Global Community Educational Foundation (NGCEF).
Srividya Swaminathan Lab, Department of Systems Biology, City of Hope - Biomedical Research Institute, California, United StatesNK Cells-based Immunotherapy; Acute Lymphoblastic Leukemia; Allergy and Osteoimmunology
B.S., M.S., Ph.D.
Member, American Society of Hematology (ASH) | 2025
DBT International Travel Grant | Govt. of India | 2016
Senior Research Fellowship (CSIR) | Govt. of India | 2014-2019
Junior Research Fellowship (CSIR) | Govt. of India | 2012-2014
Qualified CSIR-JRF Exam (Rank 29) | 2011
Graduate Aptitude Test in Engineering (GATE-2011) | Qualified
National Eligibility Test Lectureship (NET) | Qualified, 2010
Heart and Vascular Institute, Hershey Medical Center Pennsylvania State University, Hershey, United StatesCardiovascular diseases; Immunology; Cell biology and physiology; Molecular biology; Heart failure; Myocardial infarction
Dr. Vinay Kumar holds a master's degree in biotechnology from Himachal Pradesh University, Shimla, India, as well as a PhD in Molecular Biology and Genetic Engineering from Jawaharlal Nehru University, New Delhi, India. Presently at Pennsylvania State University, he conducts thorough studies of dysregulated innate and adaptive immunological networks and their function in modulating the pathophysiology of myocardial infarction (MI) and chronic heart failure (HF).
Dr. Kumar is especially interested in determining the function of T-cell subsets and the time-dependent phenotypic changes that these cells endure during chronic HF. In addition, he is interested in identifying and devising novel strategies to reverse pathological changes in immune cells in preparation for their transition from the laboratory to the clinic. His training in physiology, immunology, and molecular biology equips him with unique perspectives to research heart failure and develop mechanism-based, clinically applicable immune-therapeutic strategies.
Michigan Neuroscience Institute, University of Michigan, Michigan, United StatesPsychiatric disorders; Monoaminergic systems; GABAergic systems; Anxiety; Stress; Depression; Substance abuse; Genetic basis of emotionality; Developmental basis of Emotionality; Cellular and molecular neuroanatomy of rodent and pstmortem human brain; Light sheet microscopy; Large image-data analysis; Multiplexed fluorescence in situ hybridization; Brain transparency techniques; iDISCO
A major focus of Dr. Kumar's research involves transcript-based characterization of monoaminergic interplay in normal postmortem human brains and its potential association with psychiatric disorders including schizophrenia and major depressive disorders.
Collaborative research interests emphasize on understanding the genetic and developmental basis of inherent individual differences in emotionality, and the implications for vulnerability to anxiety, depression and substance abuse using animal models.
To address above biological questions and to perform gene expression studies in intact regions of postmortem human and whole rodent brains, Dr. Kumar is interested in the development and application of cellular and molecular neuroanatomical methods including multiplexed fluorescence in situ hybridization, brain transparency techniques, light sheet microscopy and large image-data analysis.
Michigan Neuroscience Institute, University of Michigan, Michigan, United StatesPsychiatric disorders; Monoaminergic systems; GABAergic systems; Anxiety; Stress; Depression; Substance abuse; Genetic basis of emotionality; Developmental basis of Emotionality; Cellular and molecular neuroanatomy of rodent and pstmortem human brain; Light sheet microscopy; Large image-data analysis; Multiplexed fluorescence in situ hybridization; Brain transparency techniques; iDISCO
A major focus of Dr. Kumar's research involves transcript-based characterization of monoaminergic interplay in normal postmortem human brains and its potential association with psychiatric disorders including schizophrenia and major depressive disorders.
Collaborative research interests emphasize on understanding the genetic and developmental basis of inherent individual differences in emotionality, and the implications for vulnerability to anxiety, depression and substance abuse using animal models.
To address above biological questions and to perform gene expression studies in intact regions of postmortem human and whole rodent brains, Dr. Kumar is interested in the development and application of cellular and molecular neuroanatomical methods including multiplexed fluorescence in situ hybridization, brain transparency techniques, light sheet microscopy and large image-data analysis.
Department of Urology/Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, United StatesMolecular and Human Genetics; Pharmaco-Epi-genetics; Clinical Oncology; Biotherapeutics
Huashan Hospital, Fudan University, Shanghai, ChinaMitochondrial Dynamics; Stem Cells; Macrophage Polarization; Extracellular Vesicles
Professor, Research Director at Fudan University.
Dr. Zhiwen Luo, Executive Director of Fudan University-Dr.Kong Joint Laboratory of Sports Medicine. Director Assistant, Institute of Sports Medicine, Huashan Hospital. Holds editorial roles as EIC/Associate Editor/Editorial Board/Youth Editorial Board for 40 academic journals, reviewer for over 80 SCI journals, and guest editor for over 10 SCI journals, such as Materials Today.
Friedrich-Loeffler-Institut, Institute of Bacterial Infections and Zoonoses, Jena, GermanyAntimicrobial Resistance; WGS; Epidemiology; Genetics; Antimicrobial Susceptibility Testing; Molecular Biology; Animal Production; Mass Spectrometry; Zoonotic Diseases; Foodborne Pathogens; Food Hygiene and Control
Dr. Amira Moawad is currently working as a Professor at Animal Health Research Institute. She became from 2016 until now a scientific researcher at Friedrich-Loeffler-Institute. Her PhD was on different mechanisms of antimicrobial resistance in pathogens of human and animal origin in FU Berlin. She practices research in Microbiology and Molecular Biology. Since 2017, she has cooperated in international Projects funded by German federal foreign Office. She is concerned with One Health and WGS
Researcher in Internal Medicine, Department of Translational Medical Sciences, University of Naples Federico II,Via S, Naples, ItalyImmunological Mechanisms; Autoimmune Diseases; Bradykinin-mediated Angioedema
Dr. Ilaria Mormile, M.D., Ph.D, is Assistant Professor (RTDA) in the Department of Translational Medical Sciences, University of Naples “Federico II”, dedicated and engaged in scientific research in the field of Allergy, Clinical Immunology, and Rheumatology. During her formative years, she focused on the immunological mechanisms involved in allergic and autoimmune diseases, in particular studying bradykinin-mediated angioedema.
Associate Specialist IV, UCI MIND, University of California, Irvine, California, United StatesBioinformatics; Genomics; Proteomics; Single-Cell Multi-omics; and Translational Neuroscience
Dr. Madhu Sudhana Saddala, Ph.D, working as a Bioinformatics Scientist in the University of California, Irvine, CA. USA
Department of Neurology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, ChinaNeurology; Stroke; Circadian Rhythm; Neuroprotection
MD Neurology, Shanghai East Hospital affiliated with Tongji University
Founder, " NEDOL (Nepalese Doctors Lounge)"
Author, " A Journey into the Human Body, 2013", 1st edition
Past Executive Board (Junior Doctors Committee under Nepal Medical Association)
Academic Coordinator for MBBS (Dali University, 2016 )
ICRT (Harvard Medical School, USA)
The Prince of Wales Hospital, the Chinese University of Hong Kong, Hong Kong, ChinaUrologic Cancers; Prostatic Diseases
National Cancer Institute, NIH, United StatesTumor Biology; Pancreatic Cancer; MiRNAs; Molecular Mechanism of Cancer; Translational Medicine; Biomarkers
Staff Scientist, Laboratory of Human Carcinogenesis, NCI, NIH, Bethesda, MD
Fellows Award for Research Excellence (FARE), NIH, 2018
Outstanding research in the field of pancreatic cancer and treatment, current advances in
pancreatic cancer research and treatment poster presentation award, NIH, 2014
Excellent Doctoral Dissertation, Peking Union Medical College, Tsinghua University, 2013
Second-class scholarships of Peking Union Medical College, Tsinghua University, 2009, 2011
Excellent graduate student of Jiangsu Normal University, 2008
Excellence Award of National English Contest for College Students, 2004
First-class scholarships of Jiangsu Normal University, 2001, 2002, 2004
Guangzhou Institute of Biomedicine and Health, Chinese Academy of Sciences (GIBH), Guangdong, ChinaiPSC; Pluripotent Stem Cells; Reprogramming; Nuclear Reprogramming; Cytoplasm; Mitochondria; Somatic Cell Reprogramming; Mitochondrial DNA; Reactive Oxygen Species; Mitochondrial Dynamics
Associate researcher at Chinese Academy of Sciences
University of Chinese Academy of Sciences, Beijing, ChinaPCR; Gel Electrophoresis; DNA Extraction; Electrophoresis; RNA Isolation; DNA Gel Electrophoresis; DNA Amplification; Agarose Gel Electrophoresis; RNA; DNA Sequencing
Research Associate, University of Chinese Academy of Sciences (UCAS), China.
Department of Dental Implantology, College & Hospital of Stomatology, Anhui Medical University, Key Laboratory of Oral Diseases Research of Anhui Province, Hefei, Anhui, ChinaCellular Biology & Molecular Biology of Bone Aging; Stem Cell Lineage Fates related Epigenetic Regulation; 3D Genomics; Stem Cell-based Therapy for Bone Regeneration; Screening of Jaw Bone Loss related Risk Factors
Doctor of Medicine, Associate professor at Anhui Medical University.
Since 2021, Dr. Zhang has held positions at Anhui Medical University, advancing from a lecturer to an associate professor. Recognized as a Category D high-level talent in Hefei City (a municipal leading talent), he is a Doctor of Dental Medicine, an attending doctor, and a mentor for master's students.
General Hospital of People's Liberation Army, Beijing, ChinaSepsis; Autophagy; Cell Death; Colorectal Cancer; Gastric Cancer; Bibliometrics
1. Centre for Precision Health, Edith Cowan University, 270 Joondalup Drive, Perth, WA 6027, Australia; 2. School of Medical and Health Sciences, Edith Cowan University, 270 Joondalup Drive, Perth, WA 6027, AustraliaGenomics; Glycomics
Department of Medical Biotechnology, School of Paramedical Sciences, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, IranBioinformatics; Gene Expression; Epstein Barr Virus; Cancer Research; microRNA
Center of Excellence in Environmental Studies, King Abdul Aziz University, Jeddah P.O Box: 80216, Jeddah 21589, KSA.Antimicrobial Agents; Nanoformulation; Silver Nanoparticles; Phosphate Solubilization; Biofilm
Medical Science and Technology Innovation Center, Shandong First Medical University, 271000, Jinan, ChinaCancer Proteomics and Proteoformics; Cancer Multiomics and Biomarkers; Molecular Targets for 3P Medicine and Precision Medicine in Cancer
Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USAGene and Immunotherapy for Vascular Diseases; Ageing; Neurobiology; CVD
Leading scientist of the molecular nanomedicine lab, Department of translational medicine, Sirius University of Science and Technology, Krasnodar,RussiaNanomedicine; Immune Metabolism; Cancer; Sepsis; Pulmonary Biology
Rogel Cancer Center, University of Michigan, Ann Arbor, MI48109, USACancer Biology; Tumor Microenvironment; Lymphoma